DE3716685A1 - Use of N-organo-oxycarbamidates for controlling endoparasites, novel N-organo-oxycarbamidates, and processes for their preparation - Google Patents
Use of N-organo-oxycarbamidates for controlling endoparasites, novel N-organo-oxycarbamidates, and processes for their preparationInfo
- Publication number
- DE3716685A1 DE3716685A1 DE19873716685 DE3716685A DE3716685A1 DE 3716685 A1 DE3716685 A1 DE 3716685A1 DE 19873716685 DE19873716685 DE 19873716685 DE 3716685 A DE3716685 A DE 3716685A DE 3716685 A1 DE3716685 A1 DE 3716685A1
- Authority
- DE
- Germany
- Prior art keywords
- spp
- formula
- alkynyl
- alkenyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 19
- 230000008569 process Effects 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 244000079386 endoparasite Species 0.000 title claims abstract description 11
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 29
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 22
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 21
- 125000003118 aryl group Chemical group 0.000 claims abstract description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims description 49
- 150000002148 esters Chemical class 0.000 claims description 23
- 239000002253 acid Substances 0.000 claims description 22
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- 150000002443 hydroxylamines Chemical class 0.000 claims description 12
- 150000002367 halogens Chemical class 0.000 claims description 11
- 125000005843 halogen group Chemical group 0.000 claims description 10
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 7
- 150000007513 acids Chemical class 0.000 claims description 4
- 150000004651 carbonic acid esters Chemical class 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims description 4
- 150000001714 carbamic acid halides Chemical class 0.000 claims description 3
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000004606 Fillers/Extenders Substances 0.000 claims 1
- -1 methoxy, ethoxy Chemical group 0.000 description 45
- 239000004480 active ingredient Substances 0.000 description 29
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 239000000243 solution Substances 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 16
- 239000000460 chlorine Substances 0.000 description 16
- 229910052801 chlorine Inorganic materials 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 15
- 229910052731 fluorine Inorganic materials 0.000 description 15
- 239000011737 fluorine Substances 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 14
- 239000002585 base Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 12
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical group CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 11
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 10
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 10
- 229910052794 bromium Inorganic materials 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 8
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 8
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 8
- 239000003085 diluting agent Substances 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 8
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 239000002562 thickening agent Substances 0.000 description 7
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 6
- 241000244206 Nematoda Species 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 235000013601 eggs Nutrition 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 244000045947 parasite Species 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 5
- 241001494479 Pecora Species 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 150000002170 ethers Chemical class 0.000 description 5
- 150000007529 inorganic bases Chemical class 0.000 description 5
- 150000002576 ketones Chemical class 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 4
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 4
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 4
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000012973 diazabicyclooctane Substances 0.000 description 4
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 150000002191 fatty alcohols Chemical class 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000007903 gelatin capsule Substances 0.000 description 4
- ZTOMUSMDRMJOTH-UHFFFAOYSA-N glutaronitrile Chemical compound N#CCCCC#N ZTOMUSMDRMJOTH-UHFFFAOYSA-N 0.000 description 4
- 150000008282 halocarbons Chemical class 0.000 description 4
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 239000004611 light stabiliser Substances 0.000 description 4
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 4
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N methyl iso-propyl ketone Natural products CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- 150000007530 organic bases Chemical class 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 4
- 150000003512 tertiary amines Chemical class 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- ONQBOTKLCMXPOF-UHFFFAOYSA-N 1-ethylpyrrolidine Chemical compound CCN1CCCC1 ONQBOTKLCMXPOF-UHFFFAOYSA-N 0.000 description 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- NXLNNXIXOYSCMB-UHFFFAOYSA-N (4-nitrophenyl) carbonochloridate Chemical compound [O-][N+](=O)C1=CC=C(OC(Cl)=O)C=C1 NXLNNXIXOYSCMB-UHFFFAOYSA-N 0.000 description 2
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 description 2
- OKWUYBGGPXXFLS-UHFFFAOYSA-N 1-chlorobut-2-yne Chemical compound CC#CCCl OKWUYBGGPXXFLS-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- LZILFXHGPBJADI-UHFFFAOYSA-N 2-(2-hydroxypropoxy)propan-1-ol;nonanoic acid Chemical compound CC(O)COC(C)CO.CCCCCCCCC(O)=O LZILFXHGPBJADI-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- 241000204727 Ascaridia Species 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000242711 Fasciola hepatica Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 241000243974 Haemonchus contortus Species 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 241000869417 Trematodes Species 0.000 description 2
- 241000243796 Trichostrongylus colubriformis Species 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000005530 alkylenedioxy group Chemical group 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000004995 haloalkylthio group Chemical group 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Polymers OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- RYWGPCLTVXMMHO-UHFFFAOYSA-N (4-chlorophenyl) carbonochloridate Chemical compound ClC(=O)OC1=CC=C(Cl)C=C1 RYWGPCLTVXMMHO-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 description 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- 125000006649 (C2-C20) alkynyl group Chemical group 0.000 description 1
- 125000006651 (C3-C20) cycloalkyl group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Polymers FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- IBODDUNKEPPBKW-UHFFFAOYSA-N 1,5-dibromopentane Chemical compound BrCCCCCBr IBODDUNKEPPBKW-UHFFFAOYSA-N 0.000 description 1
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- XUJLWPFSUCHPQL-UHFFFAOYSA-N 11-methyldodecan-1-ol Chemical compound CC(C)CCCCCCCCCCO XUJLWPFSUCHPQL-UHFFFAOYSA-N 0.000 description 1
- BHFLSZOGGDDWQM-UHFFFAOYSA-N 1h-benzimidazole;carbamic acid Chemical class NC(O)=O.C1=CC=C2NC=NC2=C1 BHFLSZOGGDDWQM-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-UHFFFAOYSA-N 2-(1,2-dihydroxyethyl)oxolane-3,4-diol Polymers OCC(O)C1OCC(O)C1O JNYAEWCLZODPBN-UHFFFAOYSA-N 0.000 description 1
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- BOFRXDMCQRTGII-UHFFFAOYSA-N 619-08-9 Chemical compound OC1=CC=C([N+]([O-])=O)C=C1Cl BOFRXDMCQRTGII-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001617415 Aelurostrongylus Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical class [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 241001547413 Amidostomum Species 0.000 description 1
- 241001147672 Ancylostoma caninum Species 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 241001516584 Andrya Species 0.000 description 1
- 241000415078 Anemone hepatica Species 0.000 description 1
- 241000243791 Angiostrongylus Species 0.000 description 1
- 241000252073 Anguilliformes Species 0.000 description 1
- 241000244023 Anisakis Species 0.000 description 1
- 241001626718 Anoplocephala Species 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000760149 Aspiculuris Species 0.000 description 1
- 241001448292 Austrobilharzia Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000999616 Avitellina Species 0.000 description 1
- 241001284802 Bertiella <tapeworm> Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241001323427 Bothridium Species 0.000 description 1
- 241001262976 Brachylaima Species 0.000 description 1
- 241000244036 Brugia Species 0.000 description 1
- 241000283698 Bubalus Species 0.000 description 1
- 241000931178 Bunostomum Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 125000003358 C2-C20 alkenyl group Chemical group 0.000 description 1
- VNXYYVQFJPOHPF-UHFFFAOYSA-N CCOC(=O)NOCC#C Chemical compound CCOC(=O)NOCC#C VNXYYVQFJPOHPF-UHFFFAOYSA-N 0.000 description 1
- 241001126289 Calicophoron Species 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 241000253350 Capillaria Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000614965 Catatropis Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700112 Chinchilla Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241001327942 Clonorchis Species 0.000 description 1
- 241000085576 Collyriclum Species 0.000 description 1
- 241001126268 Cooperia Species 0.000 description 1
- 241000512048 Cotylophoron Species 0.000 description 1
- 241000986238 Crenosoma Species 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 241001133296 Cyathostoma Species 0.000 description 1
- 241000217886 Cyclocoelum Species 0.000 description 1
- 241000244152 Cyclophyllidea Species 0.000 description 1
- 241001235115 Cylicostephanus Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241001262815 Dactylogyrus Species 0.000 description 1
- 241000283014 Dama Species 0.000 description 1
- 241000577452 Dicrocoelium Species 0.000 description 1
- 241001147667 Dictyocaulus Species 0.000 description 1
- 241001389925 Digenea <Rhodophyta> Species 0.000 description 1
- 241001222688 Diorchis Species 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 241001137876 Diphyllobothrium Species 0.000 description 1
- 241001626447 Diplopylidium Species 0.000 description 1
- 241000217468 Diplostomum Species 0.000 description 1
- 241000935794 Dipylidium Species 0.000 description 1
- 241000243990 Dirofilaria Species 0.000 description 1
- 235000003550 Dracunculus Nutrition 0.000 description 1
- 241000316827 Dracunculus <angiosperm> Species 0.000 description 1
- 241001126301 Echinostoma Species 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241001439622 Elaphostrongylus Species 0.000 description 1
- 241000578375 Enoplida Species 0.000 description 1
- 241000498256 Enterobius Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000144295 Eurytrema Species 0.000 description 1
- 241001126309 Fasciolopsis Species 0.000 description 1
- HMCCXLBXIJMERM-UHFFFAOYSA-N Febantel Chemical compound C1=C(NC(NC(=O)OC)=NC(=O)OC)C(NC(=O)COC)=CC(SC=2C=CC=CC=2)=C1 HMCCXLBXIJMERM-UHFFFAOYSA-N 0.000 description 1
- 241000986243 Filaroides Species 0.000 description 1
- 241001652048 Fischoederius Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241001448191 Gigantobilharzia Species 0.000 description 1
- 241000284013 Gigantocotyle Species 0.000 description 1
- 241000866662 Gigantorhynchida Species 0.000 description 1
- 241000880292 Gnathostoma Species 0.000 description 1
- 241001167431 Gongylonema Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241001636403 Gyalocephalus Species 0.000 description 1
- 241001523601 Gyrodactylus Species 0.000 description 1
- 241000315566 Habronema Species 0.000 description 1
- 241000920462 Heterakis Species 0.000 description 1
- 241001491880 Heterophyes Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 241001464082 Hydatigera Species 0.000 description 1
- 241001547406 Hyostrongylus Species 0.000 description 1
- 241001626440 Joyeuxiella Species 0.000 description 1
- 241000990101 Leucochloridium Species 0.000 description 1
- 241000360065 Ligula Species 0.000 description 1
- 241000244011 Litomosoides Species 0.000 description 1
- 241000866639 Macracanthorhynchus Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000520690 Mesocestoides Species 0.000 description 1
- 241000699673 Mesocricetus auratus Species 0.000 description 1
- 241001660197 Metagonimus Species 0.000 description 1
- 241000556230 Metastrongylus Species 0.000 description 1
- 241001549582 Metorchis Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000274183 Micromeria Species 0.000 description 1
- 241001137878 Moniezia Species 0.000 description 1
- 241000700601 Moniliformis Species 0.000 description 1
- 241001524040 Monogenea Species 0.000 description 1
- 241000986227 Muellerius Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical class CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 241001501625 Nanophyetus Species 0.000 description 1
- 241001137882 Nematodirus Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 241001126259 Nippostrongylus brasiliensis Species 0.000 description 1
- 241000520254 Oesophagodontus Species 0.000 description 1
- 241000510960 Oesophagostomum Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000863910 Ollulanus Species 0.000 description 1
- 241000243981 Onchocerca Species 0.000 description 1
- 241000242716 Opisthorchis Species 0.000 description 1
- 241001448188 Ornithobilharzia Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001221709 Oxyurida Species 0.000 description 1
- 241000904715 Oxyuris Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000648839 Parabronema Species 0.000 description 1
- 241001480233 Paragonimus Species 0.000 description 1
- 241000531596 Paramphistomum Species 0.000 description 1
- 241001234663 Paranoplocephala Species 0.000 description 1
- 241000244187 Parascaris Species 0.000 description 1
- 241001344126 Parelaphostrongylus Species 0.000 description 1
- 241000069686 Passalurus Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241001277123 Physaloptera Species 0.000 description 1
- 241001657532 Plagiorchis Species 0.000 description 1
- 241000331522 Polystoma Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000578525 Posthodiplostomum Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000522483 Poteriostomum Species 0.000 description 1
- 241000282330 Procyon lotor Species 0.000 description 1
- 241000753253 Prosthenorchis Species 0.000 description 1
- 241000408369 Prosthogonimus Species 0.000 description 1
- 241001617421 Protostrongylus Species 0.000 description 1
- 241001137874 Pseudophyllidea Species 0.000 description 1
- 241001222576 Raillietina Species 0.000 description 1
- 241000283011 Rangifer Species 0.000 description 1
- 241000316146 Salmo trutta trutta Species 0.000 description 1
- 241001222586 Schistocephalus Species 0.000 description 1
- 241000242678 Schistosoma Species 0.000 description 1
- 235000005775 Setaria Nutrition 0.000 description 1
- 241000232088 Setaria <nematode> Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241000203992 Spirometra Species 0.000 description 1
- 241000244042 Spirurida Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000843044 Stilesia Species 0.000 description 1
- 241000243788 Strongylida Species 0.000 description 1
- 241000244174 Strongyloides Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241001220316 Syngamus Species 0.000 description 1
- 241000975704 Syphacia Species 0.000 description 1
- 241001477954 Thelazia Species 0.000 description 1
- 241000999614 Thysaniezia Species 0.000 description 1
- 241000607216 Toxascaris Species 0.000 description 1
- 241000607143 Toxascaris leonina Species 0.000 description 1
- 241000244031 Toxocara Species 0.000 description 1
- 241000242541 Trematoda Species 0.000 description 1
- 241000243774 Trichinella Species 0.000 description 1
- 241001448053 Trichobilharzia Species 0.000 description 1
- 241001489151 Trichuris Species 0.000 description 1
- 241000530048 Triodontophorus Species 0.000 description 1
- 241001116191 Troglotrema Species 0.000 description 1
- 241000404851 Typhlocoelum Species 0.000 description 1
- 241000571986 Uncinaria Species 0.000 description 1
- 241000244002 Wuchereria Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- MAFQFCGGYLOGIA-UHFFFAOYSA-N benzyl n-hydroxy-n-prop-2-ynylcarbamate Chemical compound C#CCN(O)C(=O)OCC1=CC=CC=C1 MAFQFCGGYLOGIA-UHFFFAOYSA-N 0.000 description 1
- BPWASFOJNWYYMU-UHFFFAOYSA-N benzyl n-prop-2-ynoxycarbamate Chemical compound C#CCONC(=O)OCC1=CC=CC=C1 BPWASFOJNWYYMU-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000337 buffer salt Substances 0.000 description 1
- KFVUXNKQQOUCAH-UHFFFAOYSA-N butan-1-ol;propan-2-ol Chemical compound CC(C)O.CCCCO KFVUXNKQQOUCAH-UHFFFAOYSA-N 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 1
- 125000002603 chloroethyl group Chemical group [H]C([*])([H])C([H])([H])Cl 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- JPMJNRPHIMXRAP-UHFFFAOYSA-N cyclopropyl carbonochloridate Chemical compound ClC(=O)OC1CC1 JPMJNRPHIMXRAP-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000036576 dermal application Effects 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000002706 dry binder Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- PFRXHIHQOZQFFV-UHFFFAOYSA-N ethyl n-ethoxycarbamate Chemical compound CCONC(=O)OCC PFRXHIHQOZQFFV-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 208000006275 fascioliasis Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229960005282 febantel Drugs 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229960001330 hydroxycarbamide Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- XUOSJEIECAFSCQ-UHFFFAOYSA-N n-but-2-enoxy-n-prop-2-ynylcarbamoyl chloride Chemical compound CC=CCON(C(Cl)=O)CC#C XUOSJEIECAFSCQ-UHFFFAOYSA-N 0.000 description 1
- KYFJPFYEXYNZEA-UHFFFAOYSA-N n-ethoxy-n-prop-2-ynylcarbamoyl chloride Chemical compound CCON(C(Cl)=O)CC#C KYFJPFYEXYNZEA-UHFFFAOYSA-N 0.000 description 1
- JQXSCKZJDOYVLF-UHFFFAOYSA-N n-ethyl-n-prop-2-ynoxycarbamoyl chloride Chemical compound CCN(C(Cl)=O)OCC#C JQXSCKZJDOYVLF-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- NOTNUCJQBHXXGG-UHFFFAOYSA-N n-methoxybut-2-yn-1-amine Chemical compound CONCC#CC NOTNUCJQBHXXGG-UHFFFAOYSA-N 0.000 description 1
- ZASMLRQHNBWZRU-UHFFFAOYSA-N n-methoxyprop-2-yn-1-amine Chemical compound CONCC#C ZASMLRQHNBWZRU-UHFFFAOYSA-N 0.000 description 1
- OWPSCBJPWLENDT-UHFFFAOYSA-N n-phenylmethoxy-n-prop-2-ynylcarbamoyl chloride Chemical compound C#CCN(C(=O)Cl)OCC1=CC=CC=C1 OWPSCBJPWLENDT-UHFFFAOYSA-N 0.000 description 1
- YPKMZAKXAWZBKP-UHFFFAOYSA-N n-prop-2-enoxymethanamine Chemical compound CNOCC=C YPKMZAKXAWZBKP-UHFFFAOYSA-N 0.000 description 1
- DHEUKGDUMNGSHV-UHFFFAOYSA-N n-prop-2-ynoxy-n-prop-2-ynylcarbamoyl chloride Chemical compound C#CCN(C(=O)Cl)OCC#C DHEUKGDUMNGSHV-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- 239000004540 pour-on Substances 0.000 description 1
- 229960002957 praziquantel Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- QQKDTTWZXHEGAQ-UHFFFAOYSA-N propyl carbonochloridate Chemical compound CCCOC(Cl)=O QQKDTTWZXHEGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- YSAUAVHXTIETRK-AATRIKPKSA-N pyrantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1 YSAUAVHXTIETRK-AATRIKPKSA-N 0.000 description 1
- 229960005134 pyrantel Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- JNYAEWCLZODPBN-CTQIIAAMSA-N sorbitan Polymers OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000004544 spot-on Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/24—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing the groups, or; Thio analogues thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Die vorliegende Erfindung betrifft die Verwendung von N-Organooxycarbamidsäureestern zur Bekämpfung von Endoparasiten, neuen N-Organooxycarbamidsäureester und Verfahren zu ihrer Herstellung.The present invention relates to the use of N-organooxycarbamic acid esters for controlling endoparasites, new N-organooxycarbamic acid esters and processes for their manufacture.
N-Organocarbamidsäureester sind bereits bekannt. Es ist jedoch nichts über ihre Verwendung gegen Endoparasiten bekannt.N-organocarbamic acid esters are already known. It is however nothing about their use against endoparasites known.
Alkyl- und Phenylcarbonyl-substituierte Hydroxylamine und ihre anthelmintische Wirkung sind bereits bekannt. Ihre Wirkung ist jedoch nicht in allen Fällen befriedigend.Alkyl and phenylcarbonyl substituted hydroxylamines and their anthelmintic effects are already known. However, their effect is not satisfactory in all cases.
-
1. Es wurde gefunden, daß N-Organooxycarbamidsäureester
der Formel I,
in welcherR¹für Alkyl, Cycloalkyl, Alkenyl, Alkinyl, Aryl
steht, die gegebenenfalls substituiert sein
können,
R²für Alkyl, Alkenyl, Alkinyl steht, die
gegebenenfalls substituiert sein können,
R³für Alkyl, Alkenyl, Alkinyl steht, die
gegebenenfalls substituiert sein können,sich zur Bekämpfung von Endoparasiten in der
Medizin und Tiermedizin eignen.
Die Verbindungen der Formel I sind teilweise bekannt und lassen sich analog zu bekannten Verfahren herstellen.1. It has been found that N-organooxycarbamic acid esters of the formula I in which R¹ is alkyl, cycloalkyl, alkenyl, alkynyl, aryl, which may be substituted, R² is alkyl, alkenyl, alkynyl which may be substituted, R³ is alkyl, alkenyl, alkynyl, which may be substituted, to combat each other of endoparasites in medicine and veterinary medicine.
Some of the compounds of the formula I are known and can be prepared analogously to known processes. - 2. Es wurden neue N-Organooxycarbamidsäureester der Formel I gefunden, in welcherR¹für Alkyl, Cycloalkyl, Alkenyl, Alkinyl, Aryl steht, die gegebenenfalls substituiert sind, R²für Alkyl, Alkenyl, Alkinyl steht, die gegebenenfalls substituiert sind, R³für Alkyl, Alkenyl, Alkinyl steht, die gegebenenfalls substituiert sind, mit der Maßgabe, daß mindestens einer der Reste R² oder R³ für Propargyl steht.2. New N-organooxycarbamic acid esters of the formula I have been found in which R¹ is alkyl, cycloalkyl, alkenyl, alkynyl, aryl, which are optionally substituted, R² is alkyl, alkenyl, alkynyl, which are optionally substituted, R³ is alkyl, alkenyl, alkynyl, which are optionally substituted, with the proviso that at least one of the radicals R² or R³ represents propargyl.
-
3. N-Organooxycarbamidsäureester der Formel I,
in welcherR¹für Alkyl, Cycloalkyl, Alkenyl, Alkinyl, Aryl
steht, die gegebenenfalls substituiert sind,
R²für Alkyl, Alkenyl, Alkinyl steht, die gegebenenfalls
substituiert sind,
R³für Alkyl, Alkenyl, Alkinyl steht, die gegebenenfalls
substituiert sind,
mit der Maßgabe, daß mindestens einer der
Reste R² oder R³ für Propargyl steht,werden hergestellt, indem man
- a) Hydroxylaminderivate der Formel II,
in welcher
R¹ und R² die oben angegebene Bedeutung haben,
mit Verbindungen der Formel III,R³-X (III)in welcherR³die oben angegebene Bedeutung hat und Xfür Halogen oder p-Tolylsulfonyl steht,in Gegenwart von Basen umsetzt, oder - b) Kohlensäureester der Formel IV,
in welcherR¹die oben angegebene Bedeutung hat und
Yfür Halogen, Azido oder den Rest -O-R¹
steht,mit Hydroxylaminderivaten der Formel V oder
ihren Salzen mit Säuren,
in welcher
R² und R³ die oben angegebene Bedeutung
haben,
in Gegenwart von Basen umsetzt, oder - c) Hydroxylaminderivate der Formel VI,
in welcher
R¹ und R³ die oben angegebene Bedeutung
haben,
mit Verbindungen der Formel VII,R²-X (VII)in welcher X und R² die oben angegebene Bedeutung haben,
in Gegenwart von Basen umsetzt, oder - d) Carbamidsäurehalogenide der Formel VIII,
in welcherHalfür Halogen steht,
R² und R³die oben angegebene Bedeutung
haben,mit Verbindungen der Formel IX,R¹-OH (IX)in welcher
R¹ die oben angegebene Bedeutung hat,
in Gegenwart von Basen umsetzt.
- a) hydroxylamine derivatives of the formula II, in which R¹ and R² have the meaning given above,
with compounds of the formula III, R³-X (III) in which R³ has the meaning given above and X represents halogen or p-tolylsulfonyl, in the presence of bases, or - b) carbonic acid esters of the formula IV, in which R¹ has the meaning given above and Y represents halogen, azido or the radical -O-R¹, with hydroxylamine derivatives of the formula V or their salts with acids, in which R² and R³ have the meaning given above,
in the presence of bases, or - c) hydroxylamine derivatives of the formula VI, in which R¹ and R³ have the meaning given above,
with compounds of the formula VII, R²-X (VII) in which X and R² have the meaning given above,
in the presence of bases, or - d) carbamic acid halides of the formula VIII, in whichHal is halogen, R² and R³ have the meaning given above, with compounds of the formula IX, R¹-OH (IX) in which R¹ has the meaning given above,
implemented in the presence of bases.
- a) Hydroxylaminderivate der Formel II,
in welcher
R¹ und R² die oben angegebene Bedeutung haben,
Die Verbindungen der Formel I eignen sich hervorragend zur Bekämpfung von Endoparasiten, besonders auf dem Gebiet der Veterinärmedizin. Daneben lassen sie sich auch als Insektizide, Fungizide und Herbizide auf den Gebieten der Land- und Fortwirtschaft sowie Haushalt, Hygiene, Vorrats- und Materialschutz einsetzen.The compounds of the formula I are outstandingly suitable to fight endoparasites, especially on the Field of veterinary medicine. In addition, they let themselves be also as insecticides, fungicides and herbicides on the Areas of agriculture, forestry and household, Use hygiene, supply and material protection.
Bevorzugt sind Verbindungen der Formel I, in welcherCompounds of the formula I in which
R¹für C1-20-Alkyl, C2-20-Alkenyl, C3-20-Cycloalkyl, C2-20-Alkinyl, Phenyl oder Naphthyl steht wobei diese Reste durch einen oder mehrere der folgenden Substituenten substituiert sein können: Alkyl mit vorzugsweise 1 bis 4, insbesondere 1 oder 2 Kohlenstoffatomen, wie Methyl, Ethyl, n.- und i.- Propyl und n.-, i.-, s.- und t.-Butyl; Alkoxy mit vorzugsweise 1 bis 4, insbesondere 1 oder 2 Kohlenstoffatomen, wie Methoxy, Ethoxy, n.- und i.-Propyloxy und n.-, i.-, s.- und t.-Butyloxy; Alkylthio mit vorzugsweise 1 bis 4, insbesondere 1 oder 2 Kohlenstoffatomen, wie Methylthio, Ethylthio, n.- und i.-Propylthio und n.-, i.-, s.- und t.-Butylthio; Halogenalkyl mit vorzugsweise 1 bis 4, insbesondere 1 oder 2 Kohlenstoffatomen und vorzugsweise 1 bis 5, insbesondere 1 bis 3 Halogenatomen, wobei die Halogenatome gleich oder verschieden sind und als Halogenatomen, vorzugsweise Fluor, Chlor oder Brom, insbesondere Fluor stehen, wie Trifluormethyl, Fluor-, Chlorethyl; Halogenalkoxy mit vorzugsweise 1 bis 4, insbesondere 1 oder 2 Kohlenstoffatomen und vorzugsweise 1 bis 5, insbesondere 1 bis 3 Halogenatomen, wobei die Halogenatome gleich oder verschieden sind und als Halogenatome vorzugsweise Fluor, Chlor, Brom, insbesondere Fluor stehen wie Trifluormethoxy; Halogenalkylthio mit vorzugsweise 1 bis 4, insbesondere 1 oder 2 Kohlenstoffatomen und vorzugsweise 1 bis 5, insbesondere 1 bis 3 Halogenatomen, wobei die Halogenatome gleich oder verschieden sind und als Halogenatome vorzugsweise Fluor, Chlor, Brom, insbesondere Fluor stehen, wie Trifluormethylthio; im Falle von Phenyl, für Alkylendioxy mit vorzugsweise 1 oder 2 Kohlenstoffatomen wie Methylendioxy oder Ethylendioxy; im Falle von Phenyl für halogensubstituiertes Alkylendioxy mit vorzugsweise 1 oder 2 Kohlenstoffatomen und vorzugsweise 1 bis 4, insbesondere 2 bis 3 Halogenatomen, wobei die Halogenatome gleich oder verschieden sind und als Halogenatome vorzugsweise Fluor oder Chlor, insbesondere Fluor stehen wie Difluormethylendioxy, Trifluorethylendioxy, Tetrafluorethylendioxy. Weitere Substituenten sind Halogen, vorzugsweisae Fluor, Chlor, Brom und Jod, insbesondere Chlor und Brom; Cyano; Nitro; Dialkylamino mit vorzugsweise 1 bis 4, insbesondere 1 oder 2 Kohlenstoffatomen je Alkylgruppe, wie Dimethylamino, Diethylamino, Methyl-n.-butylamino; Alkylcarbonyl mit vorzugsweise 2 bis 4 Kohlenstoffatomen; Carbalkoxy mit vorzugsweise 2 bis 4, insbesondere 2 oder 3 Kohlenstoffatomen, wie Carbomethoxy und Carboethoxy; Alkylsulfonyl mit vorzugsweise 1 bis 4, insbesondere 1 oder 2 Kohlenstoffatomen, wie Methylsulfonyl und Ethylsulfonyl; Arylsulfonyl mit vorzugsweise 6 oder 10 Arylkohlenstoffatomen, wie Phenylsulfonyl; Phenyl, Naphthyl, Phenoxy, Naphthoxy, Phenylthio, Naphthylthio, die ihrerseits wieder substituiert sein können. R²für C1-6-Alkyl, C2-6-Alkenyl, C2-6-Alkinyl steht, die gegebenenfalls durch Halogen, insbesondere Chlor, Fluor, Brom, substituiert sein können, R³für C1-6-Alkyl, C2-6-Alkenyl, C2-6-Alkinyl steht, die gegebenenfalls durch Halogen, insbesondere Chlor, Fluor, Brom, substituiert sein können.R¹ is C 1-20 alkyl, C 2-20 alkenyl, C 3-20 cycloalkyl, C 2-20 alkynyl, phenyl or naphthyl, where these radicals can be substituted by one or more of the following substituents: alkyl with preferably 1 to 4, in particular 1 or 2 carbon atoms, such as methyl, ethyl, n.- and i.-propyl and n.-, i.-, s.- and t.-butyl; Alkoxy preferably having 1 to 4, in particular 1 or 2, carbon atoms, such as methoxy, ethoxy, n.- and i.-propyloxy and n.-, i.-, s.- and t.-butyloxy; Alkylthio with preferably 1 to 4, in particular 1 or 2 carbon atoms, such as methylthio, ethylthio, n.- and i.-propylthio and n.-, i.-, s.- and t.-butylthio; Haloalkyl with preferably 1 to 4, in particular 1 or 2 carbon atoms and preferably 1 to 5, in particular 1 to 3 halogen atoms, the halogen atoms being identical or different and being halogen atoms, preferably fluorine, chlorine or bromine, in particular fluorine, such as trifluoromethyl or fluorine -, chloroethyl; Halogenalkoxy with preferably 1 to 4, in particular 1 or 2 carbon atoms and preferably 1 to 5, in particular 1 to 3 halogen atoms, the halogen atoms being the same or different and preferably being fluorine, chlorine, bromine, in particular fluorine, such as trifluoromethoxy; Haloalkylthio with preferably 1 to 4, in particular 1 or 2 carbon atoms and preferably 1 to 5, in particular 1 to 3 halogen atoms, where the halogen atoms are identical or different and are preferably fluorine, chlorine, bromine, in particular fluorine, such as trifluoromethylthio; in the case of phenyl, for alkylenedioxy with preferably 1 or 2 carbon atoms, such as methylenedioxy or ethylenedioxy; in the case of phenyl for halogen-substituted alkylenedioxy with preferably 1 or 2 carbon atoms and preferably 1 to 4, in particular 2 to 3 halogen atoms, where the halogen atoms are identical or different and are preferably fluorine or chlorine, in particular fluorine, such as difluoromethylene dioxy, trifluoroethylene dioxy, tetrafluoroethylene dioxy. Further substituents are halogen, preferably fluorine, chlorine, bromine and iodine, especially chlorine and bromine; Cyano; Nitro; Dialkylamino with preferably 1 to 4, in particular 1 or 2 carbon atoms per alkyl group, such as dimethylamino, diethylamino, methyl-n-butylamino; Alkylcarbonyl preferably having 2 to 4 carbon atoms; Carbalkoxy preferably having 2 to 4, in particular 2 or 3, carbon atoms, such as carbomethoxy and carboethoxy; Alkylsulfonyl preferably having 1 to 4, in particular 1 or 2, carbon atoms, such as methylsulfonyl and ethylsulfonyl; Arylsulfonyl preferably having 6 or 10 aryl carbon atoms, such as phenylsulfonyl; Phenyl, naphthyl, phenoxy, naphthoxy, phenylthio, naphthylthio, which in turn can be substituted. R² is C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, which may optionally be substituted by halogen, in particular chlorine, fluorine, bromine, R³ is C 1-6 alkyl, C 2- 6 -Alkenyl, C 2-6 -alkynyl, which may optionally be substituted by halogen, in particular chlorine, fluorine, bromine.
Besonders bevorzugt sind Verbindungen der Formel I, in welcherCompounds of the formula I are particularly preferred in which
R¹für C1-4-Alkyl steht, das gegebenenfalls substituiert ist durch Halogen, insbesondere Chlor oder Fluor, C1-4-Alkoxy wie Methoxy oder Ethoxy, C1-4- Halogenalkoxy wie Trifluormethoxy, C1-4-Halogenalkylthio wie Trifluormethylthio, Phenyl, das gegebenenfalls substituiert ist, ferner für Phenyl steht, das gegebenenfalls substituiert ist durch C1-4-Alkyl, insbesondere Methyl, C₁-C₄-Alkoxy, insbesondere Methoxy, Ethoxy, C₁-C₄-Halogenalkoxy, insbesondere Trifluormethoxy, Fluorchlorethoxy, C₁- C₄-Halogenalkylthio, insbesondere Trifluormethylthio, Fluorchlormethylthio, C₁-C₄-Alkylthio, insbesondere Methylthio, Halogensulfonyl, insbesondere Fluorsulfonyl, Chlorsulfonyl, C₁-C₄-Alkylsulfonyl, insbesondere Methylsulfonyl, C₁-C₄-Halogenalkylsulfonyl, insbesondere Trifluormethylsulfonyl, C₁-C₄-Halogenalkyl, insbesondere Trifluormethyl, Methylendioxy oder Ethylendioxy, die gegebenenfalls durch Fluor oder Chlor substituiert sind, Halogen, insbesondere Fluor oder Chlor, NO₂, Phenoxy, das gegebenenfalls durch einen der oben angegebenen Reste substituiert ist, R²für C1-6-Alkyl, insbesondere Methyl, Ethyl, n- Propyl, i-Propyl, t-Butyl, C2-6-Alkenyl, insbesondere Allyl, Chlorpropenyl, Dichlorpropenyl, Butenyl, C2-4-Alkinyl, insbesondere Propargyl steht, R³unabhängig von R² für die bei R² angegebenen Reste steht.R 1 represents C 1-4 alkyl which is optionally substituted by halogen, in particular chlorine or fluorine, C 1-4 alkoxy such as methoxy or ethoxy, C 1-4 haloalkoxy such as trifluoromethoxy, C 1-4 haloalkylthio such as trifluoromethylthio, Phenyl, which is optionally substituted, furthermore stands for phenyl, which is optionally substituted by C 1-4 -alkyl, in particular methyl, C₁-C₄-alkoxy, in particular methoxy, ethoxy, C₁-C₄-haloalkoxy, in particular trifluoromethoxy, fluorochloroethoxy, C₁ - C₄-Haloalkylthio, especially trifluoromethylthio, fluorochloromethylthio, C₁-C₄-alkylthio, especially methylthio, halosulfonyl, especially fluorosulfonyl, chlorosulfonyl, C₁-C₄-alkylsulfonyl, especially methylsulfonyl, C₁-C₄-haloalkylsulfonyl, especially trif₄ especially trifluoromethyl, methylenedioxy or ethylenedioxy, which are optionally substituted by fluorine or chlorine, halogen, especially fluorine or chlorine, NO₂, phenoxy, the gege is also substituted by one of the radicals given above, R² for C 1-6 alkyl, in particular methyl, ethyl, n-propyl, i-propyl, t-butyl, C 2-6 alkenyl, in particular allyl, chloropropenyl, dichloropropenyl, butenyl , C 2-4 alkynyl, in particular propargyl, R³ independently of R² stands for the radicals indicated for R².
Ganz besonders bevorzugt sind Verbindungen der Formel I, in welcherCompounds of the formula are very particularly preferred I, in which
R¹für C1-4-Alkyl, insbesondere Methyl oder Ethyl, Benzyl, Phenyl, das gegebenenfalls durch Halogen, insbesondere Fluor, Chlor, NO₂, CF₃, OCF₃, SCF₃, SCF₂Cl, OCH₃, OCF₂CF₂H, -OCF₂CHFO-, -O-CH₂-O, -O-CF₂-O-substituiert ist, steht, R²für Methyl, Ethyl, n-Propyl, i-Propyl, Butyl, Pentyl, Allyl, 3-Chlor-prop-2-enyl, 2-Chlor-prop-2- enyl, 3,3-Dichlorprop-2-enyl, But-2-enyl, Propargyl steht, R³unabhängig von R² für die bei R² angegebenen Reste steht.R¹ for C 1-4 alkyl, especially methyl or ethyl, benzyl, phenyl, which may be replaced by halogen, especially fluorine, chlorine, NO₂, CF₃, OCF₃, SCF₃, SCF₂Cl, OCH₃, OCF₂CF₂H, -OCF₂CHFO-, -O-CH₂- O, -O-CF₂-O-substituted, R² is methyl, ethyl, n-propyl, i-propyl, butyl, pentyl, allyl, 3-chloroprop-2-enyl, 2-chloroprop-2 - Enyl, 3,3-dichloroprop-2-enyl, but-2-enyl, propargyl, R³ independently of R² stands for the radicals indicated for R².
Im einzelnen seien folgende Verbindungen der Formel I genannt:In particular, the following compounds of formula I are called:
Setzt man bei Verfahren 3a als Hydroxylaminderivat der Formel II Benzyloxycarbonyl-N-propargylhydroxylamin und als Verbindung der Formel III Allylbromid ein, so läßt sich der Reaktionsverlauf durch folgendes Formelschema wiedergeben:Is used in process 3a as the hydroxylamine derivative Formula II benzyloxycarbonyl-N-propargylhydroxylamine and as a compound of formula III allyl bromide, so lets the course of the reaction is shown by the following formula play:
Bevorzugt werden Verbindungen der Formel II und III eingesetzt, in denen R¹, R² und R³ die bei den Verbindungen der Formel I angegebenen bevorzugten und besonders bevorzugten Bedeutungen haben und X für Chlor, Brom oder p-Tolylsulfonyl steht.Compounds of the formula II and III are preferred used in which R¹, R² and R³ in the compounds of the formula I preferred and particularly have preferred meanings and X for chlorine, bromine or p-tolylsulfonyl.
Im einzelnen seien folgende Verbindungen der Formel II
genannt:
N-Hydroxy-N-methyl-carbamidsäure-ethylester
N-Hydroxy-N-methyl-carbamidsäure-methylester
N-Hydroxy-N-allyl-carbamidsäure-ethylester
N-Hydroxy-N-propargyl-carbamidsäure-methylester
N-Hydroxy-N-ethyl-carbamidsäure-phenylester
N-Hydroxy-N-3-chlorallyl-carbamidsäure-ethylester
N-Hydroxy-N-crotyl-carbamidsäure-isopropylester
N-Hydroxy-N-propargyl-carbamidsäure-phenylester
N-Hydroxy-N-allyl-carbamidsäure-p-chlorphenylester
N-Hydroxy-N-propargyl-carbamidsäure-cyclopropylester
The following compounds of the formula II may be mentioned in particular:
N-Hydroxy-N-methyl-carbamic acid ethyl ester
N-Hydroxy-N-methyl-carbamic acid methyl ester
N-Hydroxy-N-allyl-carbamic acid ethyl ester
N-Hydroxy-N-propargyl-carbamic acid methyl ester
N-Hydroxy-N-ethyl-carbamic acid phenyl ester
N-Hydroxy-N-3-chloroallyl-carbamic acid ethyl ester
N-hydroxy-N-crotyl-carbamic acid isopropyl ester
N-Hydroxy-N-propargyl-carbamic acid phenyl ester
N-Hydroxy-N-allyl carbamic acid p-chlorophenyl ester
N-Hydroxy-N-propargyl-carbamic acid cyclopropyl ester
Die Verbindungen der Formel II sind bekannt oder lassen sich analog zu bekannten Verfahren herstellen (Houben- Weyl, Bd. E4, S. 255, Stuttgart 1983).The compounds of formula II are known or have not are produced analogously to known processes (Houben- Weyl, vol. E4, p. 255, Stuttgart 1983).
Im einzelnen seien folgende Verbindungen der Formel III
genannt:
Methyl-, Ethyl-, Propyl-, i-Propyl-, n-Butyl-,
s-Butyl-, Allyl-, Crotyl-, 3-Chlorallyl-, 3,3-Dichlorallyl-,
2,3-Dibromallyl-, Propargyl-, 2-Butinylchlorid,
-bromid oder -tosylat.The following compounds of the formula III may be mentioned individually:
Methyl, ethyl, propyl, i-propyl, n-butyl, s-butyl, allyl, crotyl, 3-chloroallyl, 3,3-dichlorallyl, 2,3-dibromoallyl, propargyl -, 2-butynyl chloride, bromide or tosylate.
Die Verbindungen der Formel III sind bekannt oder lassen sich analog zu bekannten Verfahren herstellen.The compounds of formula III are known or have not produce themselves analogously to known processes.
Die Umsetzung erfolgt bei Temperaturen von 0-200°C, bevorzugt bei 20-100°C, besonders bevorzugt bei Siedetemperatur des Verdünnungsmittels.The reaction takes place at temperatures of 0-200 ° C, preferably at 20-100 ° C, particularly preferably at boiling temperature of the diluent.
Als Verdünnungsmittel kommen alle inerten organischen Lösungsmittel in Frage. Hierzu gehören insbesondere aliphatische und aromatische, gegebenenfalls halogenierte Kohlenwasserstoffe, wie Pentan, Hexan, Heptan, Cyclohexan, Petrolether, Benzin, Ligroin, Benzol, Toluol, Methylenchlorid, Ethylenchlorid, Chloroform, Tetrachlorkohlenstoff, Chlorbenzol und o-Dichlorbenzol, ferner Alkohole wie Methanol, Ethanol, Isopropanol, Butanol, ferner Ether wie Diethyl- und Dibutylether, Glykoldimethylether und Diglykoldimethylether, Tetrahydrofuran und Dioxan, weiterhin Ketone, wie Aceton, Methylethyl-, Methylisopropyl- und Methylisobutylketon, außerdem Ester, wie Essigsäure-methylester und -ethylester, ferner Nitrile, wie z. B. Acetonitril und Propionitril, Benzonitril, Glutarsäuredinitril, darüber hinaus Amide, wie z. B. Dimethylformamid, Dimethylacetamid und N- Methylpyrrolidon, sowie Dimethylsulfoxid, Tetramethylensulfon und Hexamethylphosphorsäuretriamid.All inert organic come as diluents Solvent in question. These include in particular aliphatic and aromatic, optionally halogenated Hydrocarbons, such as pentane, hexane, heptane, cyclohexane, Petroleum ether, petrol, ligroin, benzene, toluene, Methylene chloride, ethylene chloride, chloroform, carbon tetrachloride, Chlorobenzene and o-dichlorobenzene, further Alcohols such as methanol, ethanol, isopropanol, butanol, furthermore ethers such as diethyl and dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether, tetrahydrofuran and dioxane, furthermore ketones, such as acetone, methylethyl, Methyl isopropyl and methyl isobutyl ketone, also Esters, such as methyl acetate and ethyl acetate, also nitriles, such as. B. acetonitrile and propionitrile, Benzonitrile, glutaronitrile, and also amides, such as B. dimethylformamide, dimethylacetamide and N- Methylpyrrolidone, and also dimethyl sulfoxide, tetramethylene sulfone and hexamethylphosphoric triamide.
Als Basen kommen anorganische und organische Basen in Frage. Als Basen seien genannt Alkali- und Erdalkalihydroxide, -carbonate, -hydrogencarbonate, -alkoholate, ferner Amine wie insbesondere tertiäre Amine z. B. Trimethylamin, Triethylamin, N-Methylmorpholin, Pyridin, Picoline, N-Ethylpyrrolidin, Diazabicyclo(4,3,0)-undecan(DBU), 1,4-Diazabicyclo(2,2,2)octan (DABCO), Diazabicyclo(3,2,0)nonen (DBN).Inorganic and organic bases come in as bases Question. Alkali and alkaline earth metal hydroxides are mentioned as bases, -carbonates, -hydrogencarbonates, -alcoholates, furthermore amines such as, in particular, tertiary amines, e.g. B. trimethylamine, Triethylamine, N-methylmorpholine, pyridine, Picoline, N-ethylpyrrolidine, diazabicyclo (4,3,0) -undecane (DBU), 1,4-diazabicyclo (2,2,2) octane (DABCO), Diazabicyclo (3,2,0) nonen (DBN).
Die Verbindungen der Formeln II und III werden in etwa äquimolarem Verhältnis zueinander eingesetzt. Ein Überschuß der einen oder anderen Komponente bringt keinen wesentlichen Vorteil.The compounds of formulas II and III are approximately equimolar relationship used. An excess the one or the other component brings none significant advantage.
Nach erfolgter Umsetzung wird das Verdünnungsmittel abdestilliert und die Verbindungen der Formel I in an sich bekannter Weise isoliert, indem sie z. B. aus dem Rückstand mit einem geeigneten Lösungsmittel z. B. Ether extrahiert werden. Die Verbindungen der Formel I können anschließend in üblicher Weise z. B. durch Destillation gereinigt werden.After implementation, the diluent distilled off and the compounds of formula I in isolated in a known manner by z. B. from the Residue with a suitable solvent e.g. B. ether be extracted. The compounds of formula I can then in the usual way z. B. by distillation getting cleaned.
Setzt man bei Verfahren 3b als Kohlensäureester der Formel IV Chlorameisensäureethylester und als Hydroxylaminderivat der Formel V N-Allyl-O-propargylhydroxylamin ein, so läßt sich der Reaktionsverlauf durch folgendes Formelschema wiedergeben: If method 3b is used as the carbonic acid ester Formula IV ethyl chloroformate and as a hydroxylamine derivative of the formula V N-allyl-O-propargylhydroxylamine , the course of the reaction can be determined by the following Play formula scheme:
Bevorzugt werden Verbindungen der Formeln IV und V eingesetzt, in denen R¹, R² und R³ die bei den Verbindungen der Formel I angegebenen bevorzugten und besonders bevorzugten Bedeutungen haben und Y für Chlor steht. Die Verbindungen der Formel IV und V sind bekannt oder lassen sich analog zu bekannten Verfahren herstellen (EP-OS 29 171).Compounds of the formulas IV and V are preferred used in which R¹, R² and R³ in the compounds of the formula I preferred and particularly have preferred meanings and Y for chlorine stands. The compounds of formula IV and V are known or can be produced analogously to known processes (EP-OS 29 171).
Im einzelnen seien folgende Verbindungen der Formel IV
genannt:
Chlorameisensäuremethylester, Chlorameisensäureethylester,
Chlorameisensäure-n-propylester, Chlorameisensäure-
isopropylester, Chlorameisensäure-cyclopropylester,
Chlorameisensäurebenzylester, Chlorameisensäure-
phenylester, Chlorameisensäure-p-chlorphenylester,
Chlorameisensäure-p-nitrophenylester, Chlorameisensäure-
p-tolylester.The following compounds of the formula IV may be mentioned individually:
Methyl chloroformate, ethyl chloroformate, n-propyl chloroformate, isopropyl chloroformate, cyclopropyl chloroformate, benzyl chloroformate, p-chlorophenyl chloroformate, p-nitrophenyl chloroformate, p-nitrophenyl chloroformate.
Im einzelnen seien folgende Verbindungen der Formel V
genannt:
O,N-Diallylhydroxylamin, O,N-Dipropargylhydroxlamin, O-
Ethyl-N-allylhydroxlamin, O-Methyl-N-propargyl-hydroxylamin,
O-Propargyl-N-ethylhydroxlamin, O-Allyl-N-methylhydroxylamin,
O-Allyl-N-propargylhydroxylamin, O-Crotyl-
N-i-propylhydroxylamin, O-3-Chlorallyl-N-propargylhydroxylamin,
O-3,3-Dichlorallyl-N-allylhydroxylamin, O-
Benzyl-N-3-chlorallylhydroxylamin, O-Methyl-N-2-butinyl-
hydroxylamin.
The following compounds of the formula V may be mentioned in detail:
O, N-diallylhydroxylamine, O, N-dipropargylhydroxlamine, O- ethyl-N-allylhydroxlamine, O-methyl-N-propargyl-hydroxylamine, O-propargyl-N-ethylhydroxlamine, O-allyl-N-methylhydroxylamine, O-allyl- N-propargylhydroxylamine, O-crotyl-Ni-propylhydroxylamine, O-3-chloroallyl-N-propargylhydroxylamine, O-3,3-dichloroallyl-N-allylhydroxylamine, O-benzyl-N-3-chloroallylhydroxylamine, O-methyl-N- 2-butynyl hydroxylamine.
Die Hydroxylamine der Formel V können in Form ihrer Salze mit Säuren z. B. als Hydrochloride eingesetzt werden.The hydroxylamines of the formula V can be in the form of their Salts with acids e.g. B. can be used as hydrochloride.
Die Umsetzung erfolgt bei Temperaturen von -50 - 50°C, bevorzugt bei 0°C - 30°C, besonders bevorzugt bei Raumtemperatur.The reaction takes place at temperatures of -50 - 50 ° C, preferably at 0 ° C - 30 ° C, particularly preferably at room temperature.
Als Verdünnungsmittel kommen Wasser sowie alle inerten organischen Lösungsmittel in Frage. Hierzu gehören insbesondere aliphatische und aromatische, gegebenenfalls halogenierte Kohlenwasserstoffe, wie Pentan, Hexan, Heptan, Cyclohexan, Petrolether, Benzin, Ligroin, Benzol, Toluol, Methylenchlorid, Ethylenchlorid, Chloroform, Tetrachlorkohlenstoff, Chlorbenzol und o-Dichlorbenzol, ferner Alkohole wie Methanol, Ethanol, Isopropanol, Butanol, ferner Ether wie Diethyl- und Dibutylether, Glykoldimethylether und Diglykoldimethylether, Tetrahydrofuran und Dioxan, weiterhin Ketone, wie Aceton, Methylethyl-, Methylisopropyl- und Methylisobutylketon, außerdem Ester, wie Essigsäure-methylester und -ethylester, ferner Nitrile, wie z. B. Acetonitril und Propionitril, Benzonitril, Glutarsäuredinitril, darüber hinaus Amide, wie z. B. Dimethylformamid, Dimethylacetamid und N-Methylpyrrolidon, sowie Dimethylsulfoxid, Tetramethylensulfon und Hexamethylphosphorsäuretriamid. Water and all inert substances come as diluents organic solvents in question. These include in particular aliphatic and aromatic, optionally halogenated hydrocarbons, such as pentane, hexane, Heptane, cyclohexane, petroleum ether, gasoline, ligroin, Benzene, toluene, methylene chloride, ethylene chloride, chloroform, Carbon tetrachloride, chlorobenzene and o-dichlorobenzene, alcohols such as methanol, ethanol, isopropanol, Butanol, also ethers such as diethyl and dibutyl ether, Glycol dimethyl ether and diglycol dimethyl ether, Tetrahydrofuran and dioxane, ketones, such as Acetone, methyl ethyl, methyl isopropyl and methyl isobutyl ketone, also esters, such as methyl acetate and ethyl ester, also nitriles, such as. B. acetonitrile and propionitrile, benzonitrile, glutaronitrile, in addition amides, such as. B. dimethylformamide, dimethylacetamide and N-methylpyrrolidone and dimethyl sulfoxide, Tetramethylene sulfone and hexamethylphosphoric triamide.
Als Basen kommen anorganische und organische Basen in Frage. Als Basen seien genannt Alkali- und Erdalkalihydroxide, -carbonate, -hydrogencarbonate, -alkoholate, ferner Amine wie insbesondere tertiäre Amine z. B. Trimethylamin, Triethylamin, N-Methylmorpholin, Pyridin, Picoline, N-Ethylpyrrolidon, Diazabicyclo(4,3,0)-undecan(DBU), 1,4-Diazabicyclo(2,2,2)octan (DABCO), Diazabicyclo(3,2,0)nonen (DBN).Inorganic and organic bases come in as bases Question. Alkali and alkaline earth metal hydroxides are mentioned as bases, -carbonates, -hydrogencarbonates, -alcoholates, furthermore amines such as, in particular, tertiary amines, e.g. B. trimethylamine, Triethylamine, N-methylmorpholine, pyridine, Picoline, N-ethylpyrrolidone, diazabicyclo (4,3,0) -undecane (DBU), 1,4-diazabicyclo (2,2,2) octane (DABCO), Diazabicyclo (3,2,0) nonen (DBN).
Die Verbindungen der Formeln IV und V werden in etwa äquimolarem Verhältnis zueinander eingesetzt. Ein Überschuß der einen oder anderen Komponente bringt keinen wesentlichen Vorteil.The compounds of formulas IV and V are approximately equimolar relationship used. An excess the one or the other component brings none significant advantage.
Bevborzugt erfolgt die Umsetzung in wäßriger Lösung der Hydrochloride der Hydroxylaminderivate der Formel V mit Kohlensäureestern der Formel IV in Gegenwart wäßriger anorganischer Basen wie Kalium- oder Natriumhydroxid oder -carbonat. Nach erfolgter Umsetzung wird die Verbindung I in an sich bekannter Weise isoliert, z. B. durch Extraktion mit einem geeigneten Lösungsmittel. Der Extrakt wird mehrfach mit Wasser gewaschen, z. B. über Natriumsulfat getrocknet und dann vom Lösungsmittel befreit. Die Verbindungen der Formel I können anschließend in üblicher Weise, z. B. durch Destillation gereinigt werden.The reaction is preferably carried out in aqueous solution Hydrochloride of the hydroxylamine derivatives of formula V with Carbonic acid esters of formula IV in the presence of aqueous inorganic bases such as potassium or sodium hydroxide or carbonate. After the implementation is complete, the connection I isolated in a conventional manner, e.g. B. by extraction with a suitable solvent. The Extract is washed several times with water, e.g. B. about Dried sodium sulfate and then freed from the solvent. The compounds of formula I can then in the usual way, e.g. B. purified by distillation will.
Setzt man bei Verfahren 3c als Hydroxylaminderivat der Formel VI N-Propargyloxy-carbamidsäurebenzylester und als Verbindung der Formel VIII 1,5-Dibrompentan ein, so läßt sich der Reaktionsverlauf durch folgendes Formelschema wiedergeben: Is used in process 3c as the hydroxylamine derivative Formula VI N-propargyloxy-carbamic acid benzyl ester and as a compound of formula VIII 1,5-dibromopentane, so can the course of the reaction by the following formula play:
Bevorzugt werden Verbindungen der Formel VI und VII eingesetzt, in denen R¹, R² und R³ die bei den Verbindungen der Formel I angegebenen bevorzugten und besonders bevorzugten Bedeutungen haben und X für Chlor, Brom oder p-Tolylsulfonyl steht. Die Verbindungen der Formeln VI und VII sind bekannt oder lassen sich analog zu bekannten Verfahren herstellen (Houben-Weyl, Bd. E4, S. 258, Stuttgart, 1983).Compounds of the formulas VI and VII are preferably used, in which R¹, R² and R³ those in the compounds of the formula I preferred and particularly preferred Have meanings and X for chlorine, bromine or p-tolylsulfonyl. The compounds of the formulas VI and VII are known or can be analogous to known ones Establish process (Houben-Weyl, Vol. E4, p. 258, Stuttgart, 1983).
Im einzelnen seien folgende Verbindungen der Formel VI
genannt:
N-ethoxy-carbamidsäure-ethylester, N-Allyloxycarbamidsäureethylester,
N-Propargyloxycarbamidsäureethylester,
N-Crotylox-carbamidsäure-methylester, N-(3-
Chlorallyloxy)-carbamidsäure-methylester, N-Propargyloxycarbamidsäure-
phenylester, N-Allyloxy-carbamidsäureperchlorphenylester,
N-2-Butinyloxy-carbamidsäurephenylester.The following compounds of the formula VI may be mentioned in detail:
N-ethoxy-carbamic acid ethyl ester, N-allyloxycarbamic acid ethyl ester, N-propargyloxy carbamic acid ethyl ester, N-crotylox carbamic acid methyl ester, N- (3-chloroallyloxy) carbamic acid methyl ester, N-propargyloxy carbamic acid phenyloxy-phenyl ester, N-allyl 2-Butynyloxy carbamic acid phenyl ester.
Im einzelnen seien folgende Verbindungen der Formel VII genannt:In particular, the following compounds of formula VII called:
Methyl-, Ethyl-, n-Propyl-, i-Propyl-, n-Butyl-, i- Butyl-, n-Hexyl-, Allyl-, Crotyl-, 3-Chlorallyl-, 3,3- Dichlorallyl-, 2,3-Dibromallyl-, Propargyl-, 2-Butinylchlorid, -bromid oder -tosylat.Methyl, ethyl, n-propyl, i-propyl, n-butyl, i- Butyl, n-hexyl, allyl, crotyl, 3-chloroallyl, 3,3- Dichlorallyl, 2,3-dibromoallyl, propargyl, 2-butynyl chloride, bromide or tosylate.
Für den Fall, daß Verbindungen der Formel I hergestellt werden sollen, in denen R² für Methyl oder Ethyl steht, können als Verbindungen der Formel VII auch Dimethylsulfat oder Diethylsulfat eingesetzt werden.In the event that compounds of the formula I are prepared in which R² is methyl or ethyl, can also be used as compounds of formula VII dimethyl sulfate or diethyl sulfate can be used.
Die Umsetzung erfolgt bei Temperaturen von 0-200°C, bevorzugt bei 20-130°C, besonders bevorzugt bei Siedetemperatur des Verdünnungsmittels.The reaction takes place at temperatures of 0-200 ° C, preferably at 20-130 ° C, particularly preferably at boiling temperature of the diluent.
Als Verdünnungsmittel kommen alle inerten organischen Lösungsmittel in Frage. Hierzu gehören insbesondere aliphatische und aromatische, gegebenenfalls halogenierte Kohlenwasserstoffe, wie Pentan, Hexan, Heptan, Cyclohexan, Petrolether, Benzin, Ligroin, Benzol, Toluol, Methylenchlorid, Ethylenchlorid, Chloroform, Tetrachlorkohlenstoff, Chlorbenzol und o-Dichlorbenzol, ferner Alkohole wie Methanol, Ethanol, Isopropanol Butanol, ferner Ether wie Diethyl- und Dibutylether, Glykoldimethylether und Diglykoldimethylether, Tetrahydrofuran und Dioxan, weiterhin Ketone, wie Aceton, Methylethyl-, Methylisopropyl- und Methylisobutylketon, außerdem Ester, wie Essigsäure-methylester und -ethylester, ferner Nitrile, wie z. B. Acetonitril und Propionitril, Benzonitril, Glutarsäuredinitril, darüber hinaus Amide, wie z. B. Dimethylformamid, Dimethylacetamid und N- Methylpyrrolidon, sowie Dimethylsulfoxid, Tetramethylensulfon und Hexamethylphosphorsäuretriamid.All inert organic come as diluents Solvent in question. These include in particular aliphatic and aromatic, optionally halogenated Hydrocarbons, such as pentane, hexane, heptane, cyclohexane, Petroleum ether, petrol, ligroin, benzene, toluene, Methylene chloride, ethylene chloride, chloroform, carbon tetrachloride, Chlorobenzene and o-dichlorobenzene, further Alcohols such as methanol, ethanol, isopropanol butanol, furthermore ethers such as diethyl and dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether, tetrahydrofuran and dioxane, furthermore ketones, such as acetone, methylethyl, Methyl isopropyl and methyl isobutyl ketone, also Esters, such as methyl acetate and ethyl acetate, also nitriles, such as. B. acetonitrile and propionitrile, Benzonitrile, glutaronitrile, and also amides, such as B. dimethylformamide, dimethylacetamide and N- Methylpyrrolidone, and also dimethyl sulfoxide, tetramethylene sulfone and hexamethylphosphoric triamide.
Als Basen kommen anorganische und organische Basen in Frage. Als Basen seien genannt Alkali- und Erdalkalihydroxide, -carbonate, -hydrogencarbonate, -alkoholate, ferner Amine wie insbesondere tertiäre Amine z. B. Trimethylamin, Triethylamin, N-Methylmorpholin, Pyridin, Picoline, N-Ethylpyrrolidin, Diazabicyclo(4,3,0)-undecan(DBU), 1,4-Diazabicyclo(2,2,2)octan (DABCO), Diazabicyclo(3,2,0)nonen (DBN).Inorganic and organic bases come in as bases Question. Alkali and alkaline earth metal hydroxides are mentioned as bases, -carbonates, -hydrogencarbonates, -alcoholates, furthermore amines such as, in particular, tertiary amines, e.g. B. trimethylamine, Triethylamine, N-methylmorpholine, pyridine, Picoline, N-ethylpyrrolidine, diazabicyclo (4,3,0) -undecane (DBU), 1,4-diazabicyclo (2,2,2) octane (DABCO), Diazabicyclo (3,2,0) nonen (DBN).
Die Verbindungen der Formeln VI und VII werden in etwa äquimolarem Verhältnis zueinander eingesetzt. Ein Überschuß der einen oder anderen Komponente bringt keinen wesentlichen Vorteil.The compounds of formulas VI and VII are approximately equimolar relationship used. An excess the one or the other component brings none significant advantage.
Nach erfolgter Umsetzung wird das Verdünnungsmittel abdestilliert undd die Verbindungen der Formel I in an sich bekannter Weise isoliert, indem sie z. B. aus dem Rückstand mit einem geeigneten Lösungsmittel, z. B. Ether, extrahiert werden. Die Verbindungen der Formel I können anschließend in üblicher Weise, z. B. durch Destillation, gereinigt werden.After the reaction, the diluent is distilled off andd the compounds of formula I in themselves known manner isolated by z. B. from the residue with a suitable solvent, e.g. B. ether, be extracted. The compounds of formula I can then in the usual manner, e.g. B. by distillation, getting cleaned.
Setzt man bei Verfahren 3d als Carbamidsäurehalogenide der Formel VIII N-(2-Butenoxy)-N-propargylcarbamidsäurechlorid und als Verbindung der Formel IX Phenol ein, so läßt sich der Reaktionsmechanismus durch folgendes Formelschema wiedergeben:Is used in process 3d as carbamic acid halides of the formula VIII N- (2-butenoxy) -N-propargylcarbamic acid chloride and phenol as a compound of formula IX, so the reaction mechanism can be represented by the following formula play:
Bevorzugt werden Verbindungen der Formel VIII und IX eingesetzt, in denen R¹, R² und R³ die bei den Verbindungen der Formel I angegebenen bevorzugten und besonders bevorzugten Bedeutungen haben und Hal für Chlor oder Brom steht.Compounds of the formulas VIII and IX are preferred used in which R¹, R² and R³ in the compounds of the formula I preferred and particularly have preferred meanings and Hal for chlorine or bromine.
Die Verbindungen der Formeln VIII und IX sind bekannt oder lassen sich analog zu bekannten Verfahren herstellen. (Houben-Weyl, Bd. E4, Stuttgart 1983, S. 258).The compounds of formulas VIII and IX are known or can be produced analogously to known processes. (Houben-Weyl, Vol. E4, Stuttgart 1983, p. 258).
Im einzelnen seien folgende Verbindungen der Formel VIII
genannt:
N-Methoxy-N-allyl-carbamoylchlorid, N-Allyloxyallylcarbamoylchlorid,
N-Ethoxy-N-propargyl-carbamoylchlorid,
N-Allyloxy-N-propargyl-carbamoylchlorid, N-Propargyloxy-
N-ethyl-carbamoylchlorid, N-Benzyloxy-N-propargyl-
carbamoylchlorid, N-Propargyloxy-N-propargyl-carbamoylchlorid.The following compounds of the formula VIII may be mentioned individually:
N-methoxy-N-allyl-carbamoyl chloride, N-allyloxyallylcarbamoyl chloride, N-ethoxy-N-propargyl-carbamoyl chloride, N-allyloxy-N-propargyl-carbamoyl chloride, N-propargyloxy-N-ethyl-carbamoyl chloride, N-benzyloxy-N- propargyl-carbamoyl chloride, N-propargyloxy-N-propargyl-carbamoyl chloride.
Im einzelnen seien folgende Verbindungen der Formel IX
genannt:
Methanol, Ethanol, Propanol, Isopropanol, n-,
i-, s- und t.-Butanol, Pentanole, Hexanol, Cyclohexanol,
Allylalkohol, Propargylalkohol, Phenol, p-Kresol, p-
Chlorphenol, α-Naphthol, p-Nitrochlorphenol.The following compounds of the formula IX may be mentioned individually:
Methanol, ethanol, propanol, isopropanol, n-, i-, s- and t-butanol, pentanols, hexanol, cyclohexanol, allyl alcohol, propargyl alcohol, phenol, p-cresol, p-chlorophenol, α- naphthol, p-nitrochlorophenol.
Die Umsetzung erfolgt bei Temperaturen von -50 -50°C, bevorzugt bei 0°-30°C, besonders bei Raumtemperatur.The reaction takes place at temperatures of -50 -50 ° C, preferably at 0 ° -30 ° C, especially at room temperature.
Als Verdünnungsmittel kommen Wasser sowie alle inerten organischen Lösungsmittel in Frage. Hierzu gehören insbesondere aliphatische und aromatische, gegebenenfalls halogenierte Kohlenwasserstoffe, wie Pentan, Hexan, Heptan, Cyclohexan, Petrolether, Benzin, Ligroin, Benzol, Toluol, Methylenchlorid, Ethylenchlorid, Chloroform, Tetrachlorkohlenstoff, Chlorbenzol, und o-Dichlorbenzol, ferner Alkohole wie Methanol, Ethanol, Isopropanol, Butanol, ferner Ether wie Diethyl- und Dibutylether, Glykoldimethylether und Diglykoldimethylether, Tetrahydrofuran und Dioxan, weiterhin Ketone, wie Aceton, Methylethyl-, Methylisopropyl- und Methylisobutylketon, außerdem Ester, wie Essigsäure-methylester und -ethylester, ferner Nitrile, wie z. B. Acetonitril und Propionitril, Benzonitril, Glutarsäuredinitril, darüber hinaus Amide, wie z. B. Dimethylformamid, Dimethylacetamid und N-Methylpyrrolidon, sowie Dimethylsulfoxid, Tetramethylensulfon und Hexamethylphosphorsäuretriamid.Water and all inert substances come as diluents organic solvents in question. These include in particular aliphatic and aromatic, optionally halogenated hydrocarbons, such as pentane, hexane, Heptane, cyclohexane, petroleum ether, petrol, ligroin, benzene, Toluene, methylene chloride, ethylene chloride, chloroform, Carbon tetrachloride, chlorobenzene, and o-dichlorobenzene, alcohols such as methanol, ethanol, isopropanol, Butanol, also ethers such as diethyl and dibutyl ether, Glycol dimethyl ether and diglycol dimethyl ether, Tetrahydrofuran and dioxane, ketones, such as Acetone, methyl ethyl, methyl isopropyl and methyl isobutyl ketone, also esters, such as methyl acetate and ethyl ester, also nitriles, such as. B. acetonitrile and propionitrile, benzonitrile, glutaronitrile, in addition amides, such as. B. dimethylformamide, dimethylacetamide and N-methylpyrrolidone and dimethyl sulfoxide, Tetramethylene sulfone and hexamethylphosphoric triamide.
Als Basen kommen anorganische und organische Basen in Frage. Als Basen seien genannt Alkali- und Erdalkalihydroxide, -carbonate, -hydrogencarbonate, -alkoholate, ferner Amine wie insbesondere tertiäre Amine z. B. Trimethylamin, Triethylamin, N-Methylmorpholin, Pyridin, Picoline, N-Ethylpyrrolidin, Diazabicyclo(4,3,0)-undecan(DBU), 1,4-Diazabicyclo(2,2,2)octan (DABCO), Diazabicyclo(3,2,0)nonen (DBN).Inorganic and organic bases come in as bases Question. Alkali and alkaline earth metal hydroxides are mentioned as bases, -carbonates, -hydrogencarbonates, -alcoholates, furthermore amines such as, in particular, tertiary amines, e.g. B. trimethylamine, Triethylamine, N-methylmorpholine, pyridine, Picoline, N-ethylpyrrolidine, diazabicyclo (4,3,0) -undecane (DBU), 1,4-diazabicyclo (2,2,2) octane (DABCO), Diazabicyclo (3,2,0) nonen (DBN).
Die Verbindungen der Formeln VIII und IX werden in etwa äquimolarem Verhältnis zueinander eingesetzt. Ein Überschuß der einen oder anderen Komponente bringt keinen wesentlichen Vorteil. The compounds of formulas VIII and IX are approximately equimolar relationship used. An excess the one or the other component brings none significant advantage.
Nach erfolgter Umsetzung wird die Verbindung I in an sich bekannter Weise isoliert, z. B. durch Extraktion mit einem geeigneten Lösungsmittel. Der Extrakt wird mehrfach mit Wasser gewaschen, z. B. über Natriumsulfat getrocknet und dann vom Lösungsmittel befreit. Die Verbindungen der Formel I können anschließend in üblicher Weise, z. B. durch Destillation gereinigt werden.After the implementation, the compound I in on isolated in a known manner, e.g. B. by extraction with a suitable solvent. The extract is repeated washed with water, e.g. B. dried over sodium sulfate and then freed from the solvent. The connections of the formula I can then in the usual Way, e.g. B. cleaned by distillation.
Die Wirkstoffe eignen sich bei günstiger Warmblütertoxizität zur Bekämpfung von pathogenen Endoparasiten die bei Menschen und in der Tierhaltung und Tierzucht bei Nutz-, Zucht-, Zoo-, Labor-, Versuchs- und Hobbytieren vorkommen. Sie sind dabei gegen alle oder einzelne Entwicklungsstadien der Schädlinge sowie gegen resistente und normal sensible Arten wirksam. Durch die Bekämpfung der pathogenen Endoparasiten sollen Krankheit, Todesfälle und Leistungsminderungen (z. B. bei der Produktion von Fleisch, Milch, Wolle, Häuten, Eiern, Honig usw.) vermindert werden, so daß durch den Einsatz der Wirkstoffe eine wirtschaftlichere und einfachere Tierhaltung möglich ist. Zu den pathogenen Endoparasiten zählen Cestoden, Trematoden, Nematoden, Acantocephalen insbesondere:The active ingredients are suitable for favorable warm-blood toxicity to fight pathogenic endoparasites that in humans and in animal husbandry and animal breeding in livestock, breeding, zoo, laboratory, experimental and hobby animals occurrence. You are against everyone or some Stages of development of the pests and against resistant and normally sensitive species are effective. By fighting the pathogenic endoparasites are said to be disease, Deaths and reduced performance (e.g. during production of meat, milk, wool, skins, eggs, honey etc.) can be reduced, so that by using the Active ingredients a more economical and easier animal husbandry is possible. Pathogenic endoparasites include cestodes, trematodes, nematodes, acantocephals in particular:
Aus der Ordnung der Pseudophyllidea z. B.:
Diphyllobothrium
spp., Spirometra spp., Schistocephalus spp.,
Ligula spp., Bothridium spp., Diphlogonoporus spp.From the order of the Pseudophyllidea z. B .:
Diphyllobothrium spp., Spirometra spp., Schistocephalus spp., Ligula spp., Bothridium spp., Diphlogonoporus spp.
Aus der Ordnung der Cyclophyllidea z. B.:
Mesocestoides
spp., Anoplocephala spp., Paranoplocephala spp., Moniezia
spp., Thysanosomsa spp., Thysaniezia spp., Avitellina
spp., Stilesia spp., Cittotaenia spp., Andrya spp.,
Bertiella spp., Taenia spp., Echinococcus spp., Hydatigera
spp., Davainea spp., Raillietina spp., Hymenolepsis
spp., Echinolepsis spp., Echinocotyle spp., Diorchis
spp., Dipylidium spp., Joyeuxiella spp., Diplopylidium
spp.From the order of the Cyclophyllidea z. B .:
Mesocestoides spp., Anoplocephala spp., Paranoplocephala spp., Moniezia spp., Thysanosomsa spp., Thysaniezia spp., Avitellina spp., Stilesia spp., Cittotaenia spp., Andrya spp., Bertiella spp., Echinococ ., Hydatigera spp., Davainea spp., Raillietina spp., Hymenolepsis spp., Echinolepsis spp., Echinocotyle spp., Diorchis spp., Dipylidium spp., Joyeuxiella spp., Diplopylidium spp.
Aus der Unterklasse der Monogenea z. B.:
Gyrodactylus
spp., Dactylogyrus spp., Polystoma spp.From the subclass of Monogenea z. B .:
Gyrodactylus spp., Dactylogyrus spp., Polystoma spp.
Aus der Unterklasse der Digenea z. B.:
Diplostomum spp.,
Posthodiplostomum spp., Schistosoma spp., Trichobilharzia
spp., Ornithobilharzia spp., Austrobilharzia
spp., Gigantobilharzia spp., Leucochloridium spp.,
Brachylaima spp., Echinostoma spp., Echinoparyphium
spp., Echinochasmus spp., Hypoderaeum spp., Fasciola
spp., Fasciolides spp., Fasciolopsis spp., Cyclocoelum
spp., Typhlocoelum spp., Paramphistomum spp., Calicophoron
spp., Cotylophoron spp., Gigantocotyle spp.,
Fischoederius spp., Gastrothylacus spp., Notocotylus
spp., Catatropis spp., Plagiorchis spp., Prosthogonimus
spp., Dicrocoelium spp., Eurytrema spp., Troglotrema
spp., Paragonimus spp., Collyriclum spp., Nanophyetus
spp., Opisthorchis spp., Clonorchis spp. Metorchis spp.,
Heterophyes spp., Metagonimus spp.From the subclass of Digenea z. B .:
Diplostomum spp., Posthodiplostomum spp., Schistosoma spp., Trichobilharzia spp., Ornithobilharzia spp., Austrobilharzia spp., Gigantobilharzia spp., Leucochloridium spp., Brachylaima spp., Echinostoma spp., Echinopumochin., Echinoparyphin ., Fasciola spp., Fasciolides spp., Fasciolopsis spp., Cyclocoelum spp., Typhlocoelum spp., Paramphistomum spp., Calicophoron spp., Cotylophoron spp., Gigantocotyle spp., Fischoederius spp., Gastrothyocus. Catatropis spp., Plagiorchis spp., Prosthogonimus spp., Dicrocoelium spp., Eurytrema spp., Troglotrema spp., Paragonimus spp., Collyriclum spp., Nanophyetus spp., Opisthorchis spp., Clonorchis spp. Metorchis spp., Heterophyes spp., Metagonimus spp.
Aus der Ordnung der Enoplida z. B.
Trichuris spp.,
Capillaria spp., Trichomosoides spp., Trichinella spp.From the order of the Enoplida z. B.
Trichuris spp., Capillaria spp., Trichomosoides spp., Trichinella spp.
Aus der Ordnung der Rhabditia z. B.:
Micronema spp.,
Strongyloides spp.
From the order of the Rhabditia z. B .:
Micronema spp., Strongyloides spp.
Aus der Ordnung der Strongylida z. B.:
Stronylus spp.,
Triodontophorus spp., Oesophagodontus spp., Trichonema
spp., Gyalocephalus spp., Cylindropharynx spp., Poteriostomum
spp., Cyclococercus spp., Cylicostephanus
spp., Oesophagostomum spp., Chabertia spp., Stephanurus
spp., Ancylostoma spp., Uncinaria spp., Bunostomum spp.,
Globocephalus spp., Syngamus spp., Cyathostoma spp.,
Metastrongylus spp., Dictyocaulus spp., Muellerius spp.,
protostrongylus spp., Neostrongylus spp., Cystocaulus
spp., Pneumostrongylus spp., Spicocaulus spp., Elaphostrongylus
spp., Parelaphostrongylus spp., Crenosoma
spp., Paracrenosoma spp., Angiostrongylus spp., Aelurostrongylus
spp., Filaroides spp., Parailaroides spp.,
Trichostrongylus spp., Haemonchus spp., Ostertagia spp.,
Marshallagia spp., Cooperia spp., Nematodirus spp.,
Hyostrongylus spp., Obeliscoides spp., Amidostomum spp.,
Ollulanus spp.From the order of Strongylida z. B .:
Stronylus spp., Triodontophorus spp., Oesophagodontus spp., Trichonema spp., Gyalocephalus spp., Cylindropharynx spp., Poteriostomum spp., Cyclococercus spp., Cylicostephanus spp., Oesophagostomum spp., Stephanabostoma ., Uncinaria spp., Bunostomum spp., Globocephalus spp., Syngamus spp., Cyathostoma spp., Metastrongylus spp., Dictyocaulus spp., Muellerius spp., Protostrongylus spp., Neostrongylus spp., Cystocaulusrppyl. Spicocaulus spp., Elaphostrongylus spp., Parelaphostrongylus spp., Crenosoma spp., Paracrenosoma spp., Angiostrongylus spp., Aelurostrongylus spp., Filaroides spp., Parailaroides spp., Trichostrongyluschia. Spp., Haich. Sppia ., Cooperia spp., Nematodirus spp., Hyostrongylus spp., Obeliscoides spp., Amidostomum spp., Ollulanus spp.
Aus der Ordnung der Oxyurida z. B.
Oxyuris spp., Enterobius
spp., Passalurus spp., Syphacia spp., Aspiculuris
spp., Heterakis spp.From the order of the Oxyurida z. B.
Oxyuris spp., Enterobius spp., Passalurus spp., Syphacia spp., Aspiculuris spp., Heterakis spp.
Aus der Ordnung der Ascaridia z. B.
Ascaris spp.,
Toxascaris spp., Toxocara spp., Parascaris spp.,
Anisakis spp., Ascaridia spp.From the order of Ascaridia z. B.
Ascaris spp., Toxascaris spp., Toxocara spp., Parascaris spp., Anisakis spp., Ascaridia spp.
Aus der Ordnung der Spirurida z. B.:
Gnathostoma spp.,
Physaloptera spp., Thelazia spp., Gongylonema spp.,
Habronema spp., Parabronema spp., Draschia spp., Dracunculus
spp.
From the order of the Spirurida z. B .:
Gnathostoma spp., Physaloptera spp., Thelazia spp., Gongylonema spp., Habronema spp., Parabronema spp., Draschia spp., Dracunculus spp.
Aus der Ordnung der Filariida z. B.:
Stephanofilaria
spp., Parafilaria spp., Setaria spp., Loa spp., Dirofilaria
spp., Litomosoides spp., Brugia spp., Wuchereria
spp., Onchocerca spp.From the order of the Filariida z. B .:
Stephanofilaria spp., Parafilaria spp., Setaria spp., Loa spp., Dirofilaria spp., Litomosoides spp., Brugia spp., Wuchereria spp., Onchocerca spp.
Aus der Ordnung der Gigantorhynchida z. B.:
Filicollis
spp., Moniliformis spp., Macracanthorhynchus spp.,
Prosthenorchis spp.From the order of the Gigantorhynchida z. B .:
Filicollis spp., Moniliformis spp., Macracanthorhynchus spp., Prosthenorchis spp.
Zu den Nutz- und Zuchttieren gehören Säugetiere wie z. B. Rinder, Pferde, Schafe, Schweine, Ziegen, Kamele, Wasserbüffel, Esel, Kaninchen, Damwild, Rentiere, Pelztiere wie z. B. Nerze, Chinchilla, Waschbär, Vögel wie z. B. Hühner, Gänse, Puten, Enten, Süß- und Salzwasserfische wie z. B. Forellen, Karpfen, Aale, Reptilien, Insekten wie z. B. Honigbiene und Seidenraupe.The livestock and breeding animals include mammals such as B. Cattle, horses, sheep, pigs, goats, camels, water buffalos, Donkeys, rabbits, fallow deer, reindeer, fur animals such as B. mink, chinchilla, raccoon, birds such. B. Chickens, geese, turkeys, ducks, fresh and salt water fish such as B. trout, carp, eels, reptiles, insects such as B. honey bee and silkworm.
Zu Labor- und Versuchstieren gehören Mäuse, Ratten, Meerschweinchen, Goldhamster, Hunde und Katzen.Laboratory and experimental animals include mice, rats, Guinea pigs, golden hamsters, dogs and cats.
Zu den Hobbytieren gehören Hunde und Katzen.The pets include dogs and cats.
Die Anwendung kann sowohl prophylaktisch als auch therapeutisch erfolgen.The application can be prophylactic as well as therapeutic respectively.
Die Anwendung der Wirkstoffe erfolgt direkt oder in Form, von geeigneten Zubereitungen enteral, parenteral, dermal, nasal, durch Behandlung der Umgebung oder mit Hilfe wirkstoffhaltiger Formkörper wie z. B. Streifen, Platten, Bänder, Halsbänder, Ohrmarken, Gliedmaßenbänder, Markierungsvorrichtungen. The active ingredients are used directly or in the form of suitable preparations enterally, parenterally, dermally, nasally, by treating the environment or with the help active substance-containing shaped bodies such. B. strips, plates, Ribbons, collars, ear tags, limb straps, marking devices.
Die enterale Anwendung der Wirkstoffe geschieht z. B. oral in Form von Pulver, Tabletten, Kapseln, Pasten, Tränken, Granulaten, oral applizierbaren Lösungen, Suspensionen und Emulsionen, Boli, medikiertem Futter oder Trinkwasser. Die dermale Anwendung geschieht z. B. in Form des Tauchens (Dippen), Sprühens (Sprayen) oder Aufgießens (pour-on and spot-on). Die parenterale Anwendung geschieht z. B. in Form der Injektion (intramusculär, subcutan, intravenös, intraperitoneal) oder durch Implanate.The enteral application of the active ingredients happens, for. B. orally in the form of powder, tablets, capsules, pastes, Watering, granules, orally applicable solutions, Suspensions and emulsions, boluses, medicated feed or drinking water. The dermal application happens e.g. B. in the form of diving (dipping), spraying (spraying) or Pour-on and spot-on. The parenteral Application happens z. B. in the form of injection (intramuscular, subcutaneous, intravenous, intraperitoneal) or through implants.
Geeignete Zubereitungen sind:Suitable preparations are:
- Lösungen wie Injektionslösungen, orale Lösungen, Konzentrate zur oralen Verabreichung nach Verdünnung, Lösungen zum Gebrauch auf der Haut oder in Körperhöhlen, Aufgußformulierungen, Gele;Solutions such as injection solutions, oral solutions, concentrates for oral administration after dilution, solutions for use on the skin or in body cavities, Infusion formulations, gels;
- Emulsionen und Suspensionen zur oralen oder dermalen Anwendung sowie zur Injektion; Halbfeste Zubereitungen;Emulsions and suspensions for oral or dermal use as well as for injection; Semi-solid preparations;
- Formulierungen bei denen der Wirkstoff in einer Salbengrundlage oder in einer Öl in Wasser oder Wasser in Öl Emulsionsgrundlage verarbeitet ist;Formulations in which the active ingredient in an ointment base or in an oil in water or water in oil Emulsion base is processed;
- Feste Zubereitungen wie Pulver, Premixe oder Konzentrate, Granulate, Pellets, Tabletten, Boli, Kapseln; Aerosole und Inhalate, wirkstoffhaltige Formkörper.Solid preparations such as powders, premixes or concentrates, Granules, pellets, tablets, boluses, capsules; Aerosols and Inhaled tablets containing active ingredients.
Injektionslösungen werden intravenös, intramuskulär und subcutan verabreicht. Solutions for injection become intravenous, intramuscular and administered subcutaneously.
Injektionslösungen werden hergestellt, indem der Wirkstoff in einem geeigneten Lösungsmittel gelöst wird und eventuell Zusätze wie Lösungsvermittler, Säuren, Basen, Puffersalze, Antioxidantien, Konservierungsmittel zugefügt werden. Die Lösungen werden steril filtriert und abgefüllt.Injection solutions are made by the active ingredient is dissolved in a suitable solvent and possibly additives such as solubilizers, acids, bases, Buffer salts, antioxidants, preservatives added will. The solutions are sterile filtered and filled.
Als Lösungsmittel seien genannt:
Physiologisch verträgliche
Lösungsmittel wie Wasser, Alkohole wie Ethanol,
Butanol, Benzylalkohol, Glycerin, Propylenglykol,
Polyethylenglykole, N-Methyl-pyrrolidon, sowie Gemische
derselben.The following may be mentioned as solvents:
Physiologically acceptable solvents such as water, alcohols such as ethanol, butanol, benzyl alcohol, glycerin, propylene glycol, polyethylene glycols, N-methyl-pyrrolidone, and mixtures thereof.
Die Wirkstoffe lassen sich gegebenenfalls auch in physiologisch verträglichen pflanzlichen oder synthetischen Ölen, die zur Injektion geeignet sind, lösen.The active ingredients can optionally also be physiologically compatible vegetable or synthetic Dissolve oils that are suitable for injection.
Als Lösungsvermittler seien genannt:
Lösungsmitel, die
die Lösung des Wirkstoffs im Hauptlösungsmittel fördern
oder sein Ausfallen verhindern. Beispiele sind Polyvinylpyrrolidon,
polyoxyethyliertes Rhizinusöl, polyoxyethylierte
Sorbitanester.The following may be mentioned as solution mediators:
Solvents that promote the dissolution of the active ingredient in the main solvent or prevent its precipitation. Examples are polyvinyl pyrrolidone, polyoxyethylated castor oil, polyoxyethylated sorbitan esters.
Konservierungsmittel sind:
Benzylalkohol, Trichlorbutanol,
p-Hydroxybenzoesäureester, n-Butanol.Preservatives are:
Benzyl alcohol, trichlorobutanol, p-hydroxybenzoic acid ester, n-butanol.
Orale Lösungen werden direkt angewendet, Konzentrate werden nach vorheriger Verdünnung auf die Anwendungskonzentration oral angewendet. Orale Lösungen und Konzentrate werden wie oben bei den Injektionslösungen beschrieben hergestellt, wobei auf steriles Arbeiten verzichtet werden kann.Oral solutions are used directly, concentrates after dilution to the application concentration applied orally. Oral solutions and concentrates are as described above for the injection solutions manufactured, doing without sterile work can be.
Lösungen zum Gebrauch auf der Haut werden aufgeträufelt, aufgestrichen, eingerieben, aufgespritzt oder aufgesprüht. Diese Lösungen werden wie oben bei den Injektionslösungen beschrieben hergestellt.Solutions for use on the skin are instilled, spread on, rubbed in, sprayed on or sprayed on. These solutions are the same as for the injection solutions described manufactured.
Es kann vorteilhaft sein, bei der Herstellung Verdickungsmittel zuzufügen. Verdickungsmittel sind: Anorganische Verdickungsmittel wie Bentonite, kolloidale Kieselsäure, Aluminiummonostearat, organische Verdickungsmittel wie Cellulosederivate, Polyvinylalkohole und deren Copolymere, Acrylate und Metacrylate.It may be advantageous in the manufacture of thickeners inflict. Thickeners are: Inorganic Thickeners such as bentonites, colloidal Silica, aluminum monostearate, organic thickeners such as cellulose derivatives, polyvinyl alcohols and their copolymers, acrylates and metacrylates.
Gele werden auf die Haut aufgetragen oder aufgestrichen oder in Körperhöhlen eingebracht. Gele werden hergestellt indem Lösungen, die wie bei den Injektionslösungen beschrieben hergestellt worden sind, mit soviel Verdickungsmittel versetzt werden, daß eine klare Masse mit salbenartiger Konsistenz entsteht. Als Verdickungsmittel werden die weiter oben angegebenen Verdickungsmittel eingesetzt.Gels are applied or spread on the skin or placed in body cavities. Gels are made by providing solutions that are like injection solutions described with so much Thickeners are added that are clear Mass with ointment-like consistency arises. As Thickeners are those given above Thickeners used.
Aufgieß Formulierungen werden auf begrenzte Bereiche der Haut aufgegossen oder aufgespritzt, wobei der Wirkstoff die Haut durchdringt und systemisch wirkt. Infusion formulations are limited to areas poured or sprayed on the skin, the active ingredient penetrates the skin and has a systemic effect.
Aufgieß Formulierungen werden hergestellt, indem der Wirkstoff in geeigneten hautverträglichen Lösungsmitteln oder Lösungsmittelgemischen gelöst, suspendiert oder emulgiert wird. Gegebenenfalls werden weitere Hilfsstoffe wie Farbstoffe, resorptionsfördernde Stoffe, Antioxidantien, Lichtschutzmittel, Haftmittel zugefügt.Infusion formulations are made by the Active ingredient in suitable skin-compatible solvents dissolved or solvent mixtures, suspended or is emulsified. If necessary, more Auxiliaries such as dyes, absorption-promoting substances, Antioxidants, light stabilizers, adhesives added.
Als Lösungsmittel seien genannt:
Wasser, Alkanole, Glycole,
Polyethylenglycole, Polypropylenglycole, Glycerin,
aromatische Alkohole wie Benzylalkohol, Phenylethanol,
Phenoxyethanol, Ester wie Essigester, Butylacetat, Benzylbenzoat,
Ether wie Alkylenglykolalkylether wie Dipropylenglykolmonomethylether,
Diethylenglykolmono-butylether,
Ketone wie Aceton, Methylethylketon, aromatische
und/oder aliphatisache Kohlenwasserstoffe, pflanzliche
oder synthetische Öle, DMF, Dimethylacetamid, N-Methylpyrrolidon,
2-Dimethyl-4-oxy-methylen-1,3-dioxolan.The following may be mentioned as solvents:
Water, alkanols, glycols, polyethylene glycols, polypropylene glycols, glycerol, aromatic alcohols such as benzyl alcohol, phenylethanol, phenoxyethanol, esters such as Essigester, butyl acetate, benzyl benzoate, ethers such as alkylene glycol alkyl ethers such as dipropylene glycol monomethyl ether, diethylene glycol mono-butyl ether, ketones such as acetone, methyl ethyl ketone, aromatic and / or aliphatisache Hydrocarbons, vegetable or synthetic oils, DMF, dimethylacetamide, N-methylpyrrolidone, 2-dimethyl-4-oxy-methylene-1,3-dioxolane.
Farbstoffe sind alle zur Anwendung am Tier zugelassenen Farbstoffe, die gelöst oder suspendiert sein können.Dyes are all approved for use on animals Dyes that can be dissolved or suspended.
Resorptionsfördernde Stoffe sind z. B. DMSO, spreitende Öle wie Isopropylmyristat, Dipropylenglykolpelargonat, Silikonöle, Fettsäureester, Triglyceride, Fettalkohole.Resorption promoting substances are e.g. B. DMSO, spreading Oils such as isopropyl myristate, dipropylene glycol pelargonate, Silicone oils, fatty acid esters, triglycerides, fatty alcohols.
Antioxidantien sind Sulfite oder Metabisulfite wie Kaliummetabisulfit, Ascorbinsäure, Butylhydroxytoluol, Butylhydroxyanisol, Tocopherol.Antioxidants are sulfites or metabisulfites like Potassium metabisulfite, ascorbic acid, butylated hydroxytoluene, Butylated hydroxyanisole, tocopherol.
Lichtschutzmittel sind z. B. Novantisolsäure. Light stabilizers are e.g. B. Novantisol acid.
Haftmittel sind z. B. Cellulosederivate, Stärkederivate, Polyacrylate, natürliche Polymere wie Alginate, Gelatine.Adhesives are e.g. B. cellulose derivatives, starch derivatives, Polyacrylates, natural polymers such as alginates, Gelatin.
Emulsionen können oral, dermal oder als Injektionen angewendet werden.Emulsions can be applied orally, dermally or as injections will.
Emulsionen sind entweder vom Typ Wasser in Öl oder vom Typ Öl in Wasser.Emulsions are either of the water in oil type or of the Type oil in water.
Sie werden hergestellt, indem man den Wirkstoff entweder in der hydrophoben oder in der hydrophilen Phase löst und diese unter Zuhilfenahme geeigneter Emulgatoren und gegebenenfalls weiterer Hilfsstoffe wie Farbstoffe, resorptionsfördernde Stoffe, Konservierungsstoffe, Antioxidantien, Lichtschutzmittel, viskositätserhöhende Stoffe, mit dem Lösungsmittel der anderen Phase homogenisiert.They are made by either the active ingredient dissolves in the hydrophobic or in the hydrophilic phase and this with the help of suitable emulsifiers and optionally other auxiliaries such as dyes, absorption-promoting substances, preservatives, Antioxidants, light stabilizers, viscosity increasing Substances homogenized with the solvent of the other phase.
Als hydrophobe Phase (Öle) seien genannt: Paraffinöle, Silikonöle, natürliche Pflanzenöle wie Sesamöl, Mandelöl, Rizinusöl, synthetische Triglyceride wie Capryl/ Caprinsäure-bigylcerid, Triglyceridgemisch mit Pflanzenfettsäuren der Kettenlänge C8-12 oder anderen speziell ausgewählten natürlichen Fettsäuren, Partialglyceridgemische gesättigter oder ungesättigter eventuell auch hydroxylgruppenhaltiger Fettsäuren, Mono- und Diglyceride der C₈/C₁₀-Fettsäuren. The following may be mentioned as hydrophobic phase (oils): paraffin oils, silicone oils, natural vegetable oils such as sesame oil, almond oil, castor oil, synthetic triglycerides such as caprylic / capric acid bigylceride, triglyceride mixture with vegetable fatty acids of chain length C 8-12 or other specially selected natural fatty acids, partial glyceride mixtures saturated or unsaturated, possibly also hydroxyl-containing fatty acids, mono- and diglycerides of C₈ / C₁₀ fatty acids.
Fettsäureester wie Ethylstearat, Di-n-butyryl-adipat, Laurinsäurehexylester, Dipropylen-glykolpelargonat, Ester einer verzweigten Fettsäure mittlerer Kettenlänge mit gesättigten Fettalkoholen der Kettenlänge C₁₆-C₁₈, Isopropylmyristat, Isopropylpalmitrat, Capryl/Caprinsäureester von gesättigten Fettalkoholen der Kettenlänge C₁₂-C₁₈, Isopropylstearat, Ölsäureoleylester, Ölsäuredecylester, Ethyloleat, Milchsäureethylester, wachsartige Fettsäureester wie künstliches Entenbürzeldrüsenfett, Dibutylphthalat, Adipinsäurediisopropylester, letzterem verwandte Estergemische u. a.Fatty acid esters such as ethyl stearate, di-n-butyryl adipate, Hexyl laurate, dipropylene glycol pelargonate, Ester of a medium chain branched fatty acid with saturated fatty alcohols of chain length C₁₆-C₁₈, Isopropyl myristate, isopropyl palmitate, caprylic / capric acid ester of saturated fatty alcohols of chain length C₁₂-C₁₈, isopropyl stearate, oleic acid oleyl ester, oleic acid decyl ester, Ethyl oleate, lactic acid ethyl ester, waxy Fatty acid esters such as artificial duckling glandular fat, Dibutyl phthalate, diisopropyl adipate, the latter related ester mixtures u. a.
Fettalkohole wie Isotridecylalkohol, 2-Octyldodecanol, Cetylstearyl-alkohol, Oleylalkohol.Fatty alcohols such as isotridecyl alcohol, 2-octyldodecanol, Cetylstearyl alcohol, oleyl alcohol.
Fettsäuren wie z. B. Ölsäure und ihre Gemische.Fatty acids such as B. oleic acid and its mixtures.
Als hydrophile Phase seien genannt:
Wasser, Alkohole wie z. B. Propylenglycol, Glycerin,
Sorbitol und ihre Gemische.The following are mentioned as the hydrophilic phase:
Water, alcohols such as B. propylene glycol, glycerin, sorbitol and their mixtures.
Als Emulgatoren seien genannt:
nichtionogene Tenside,
z. B. polyoxyethyliertes Rizinusöl, polyoxyethyliertes
Sorbitan-monooleat, Sorbitanmonostearat, Glycerinmonostearat,
Polyoxyethylstearat, Alkylphenolpolyglykolether;
ampholytische Tenside wie Di-Na-N-lauryl-β-iminodipropionat
oder Lecithin;
anionaktive Tenside, wie Na-Laurylsulfat, Fettalkoholethersulfate, Mono/Dialkylpolyglykoletherorthophosphorsäureester-monoethanolaminsalz;
kationaktive Tenside wie Cetyltrimethylammoniumchlorid.The following may be mentioned as emulsifiers:
non-ionic surfactants, e.g. B. polyoxyethylated castor oil, polyoxyethylated sorbitan monooleate, sorbitan monostearate, glycerol monostearate, polyoxyethyl stearate, alkylphenol polyglycol ether;
ampholytic surfactants such as di-Na-N-lauryl- β -iminodipropionate or lecithin;
anionic surfactants such as Na lauryl sulfate, fatty alcohol ether sulfates, mono / dialkyl polyglycol ether orthophosphoric acid ester monoethanolamine salt;
cationic surfactants such as cetyltrimethylammonium chloride.
Als weitere Hilfsstoffe seien genannt:
Viskositätserhöhende
und die Emulsion stabilisierende Stoffe wie
Carboxymethylcellulose, Methylcellulose und andere
Cellulose- und Stärke-Derivate, Polyacrylate, Alginate,
Gelatine, Gummi-arabicum, Polyvinylpyrrolidon, Polyvinylalkohol,
Copolymere aus Methylvinylether und Maleinsäureanhydrid,
Polyethylenglykole, Wachse, kolloidale
Kieselsäure oder Gemische der aufgeführten
Stoffe.The following may be mentioned as further auxiliaries:
Viscosity-increasing and emulsion-stabilizing substances such as carboxymethyl cellulose, methyl cellulose and other cellulose and starch derivatives, polyacrylates, alginates, gelatin, gum arabic, polyvinyl pyrrolidone, polyvinyl alcohol, copolymers of methyl vinyl ether and maleic anhydride, polyethylene glycols, waxes, colloidal silicic acid or listed substances .
Suspensionen können oral, dermal oder als Injektion angewendet werden. Sie werden hergestellt, indem man den Wirkstoff in einer Trägerflüssigkeit gegebenenfalls unter Zusatz weiterer Hilfsstoffe wie Netzmittel, Farbstoffe, resorptionsfördernde Stoffe, Konservierungsstoffe, Antioxidantien Lichtschutzmittel suspendiert.Suspensions can be taken orally, dermally or as an injection be applied. They are made by using the Active ingredient in a carrier liquid if necessary with the addition of other auxiliaries such as wetting agents, dyes, absorption-promoting substances, preservatives, Antioxidants suspended in light stabilizers.
Als Trägerflüssigkeiten seien alle homogenen Lösungsmittel und Lösungsmittelgemische genannt.All homogeneous solvents are carrier liquids and solvent mixtures called.
Als Netzmittel (Dispergiermittel) seien die weiter oben angegebene Tenside genannt.As wetting agents (dispersants) are the above specified surfactants called.
Als weitere Hilfsstoffe seien die weiter oben angegebenen genannt. Further auxiliaries are those mentioned above called.
Halbfeste Zubereitungen können oral oder dermal verabreicht werden. Sie unterscheiden sich von den oben beschriebenen Suspensionen und Emulsionen nur durch ihre höhere Viskosität.Semi-solid preparations can be administered orally or dermally will. They differ from those described above Suspensions and emulsions only through their higher viscosity.
Zur Herstellung fester Zubereitungen wird der Wirkstoff mit geeigneten Trägerstoffen gegebenenfalls unter Zusatz von Hilfsstoffen vermischt und in die gewünschte Form gebracht.The active ingredient is used to produce solid preparations with suitable carriers, if necessary with the addition of auxiliaries mixed and into the desired shape brought.
Als Trägerstoffe seien genannt alle physiologisch verträglichen festen Inertstoffe. Alle solche dienen anorganische und organische Stoffe. Anorganische Stoffe sind z. B. Kochsalz, Carbonate wie Calciumcarbonat, Hydrogencarbonate, Aluminiumoxide, Kieselsäuren, Tonerden, gefälltes oder kolloidales Siliciumdioxid, Phosphate.All physiologically compatible are mentioned as carriers solid inert substances. All of these serve inorganic and organic matter. Inorganic substances are e.g. B. common salt, carbonates such as calcium carbonate, hydrogen carbonates, Aluminum oxides, silicas, clays, precipitated or colloidal silicon dioxide, phosphates.
Organische Stoffe sind z. B. Zucker, Zellulose, Nahrungs- und Futtermittel wie Milchpulver, Tiermehle, Getreidemehle und -schrote, Stärken.Organic substances are e.g. B. sugar, cellulose, food and feed such as milk powder, animal meal, cereal meal and meal, strengths.
Hilfsstoffe sind Konservierungsstoffe, Antioxidantien, Farbstoffe, die bereits weiter oben aufgeführt worden sind.Excipients are preservatives, antioxidants, Dyes that have already been listed above are.
Weitere geeignete Hilfsstoffe sind Schmier- und Gleitmittel wie z. B. Magnesiumstearat, Stearinsäure, Talkum, Bentonite, zerfallsfördernde Substanzen wie Stärke oder quervernetztes Polyvinylpyrrolidon, Bindemittel wie z. B. Stärke, Gelatine oder lineares Polyvinylpyrrolidon sowie Trockenbindemittel wie mikrokristalline Cellulose.Other suitable auxiliaries are lubricants and lubricants such as B. magnesium stearate, stearic acid, talc, Bentonites, decay-promoting substances such as starch or cross-linked polyvinylpyrrolidone, binders such. B. Starch, gelatin or linear polyvinylpyrrolidone as well Dry binders such as microcrystalline cellulose.
Die Wirkstoffe können in den Zubereitungen auch in Mischung mit Synergisten oder mit anderen Wirkstoffen, die gegen pathogene Endoparasiten wirken, vorliegen. Solche Wirkstoffe sind z. B. L-2,3,5,6-Tetrahydro-6-phenylimidazothiazol, Benzimidazolcarbamate, Praziquantel, Pyrantel, Febantel.The active ingredients can also be mixed in the preparations with synergists or with other active ingredients that act against pathogenic endoparasites. Such Active ingredients are e.g. B. L-2,3,5,6-tetrahydro-6-phenylimidazothiazole, Benzimidazole carbamates, praziquantel, Pyrantel, Febantel.
Anwendungsfertige Zubereitungen enthalten den Wirkstoff in Konzentrationen von 10 ppm- 20 Gewichtsprozent, bevorzugt von 0,1-10 Gewichtsprozent.Ready-to-use preparations contain the active ingredient in concentrations of 10 ppm - 20 percent by weight, preferably from 0.1-10 percent by weight.
Zubereitungen die vor Anwendung verdünnt werden, enthalten den Wirkstoff in Konzentrationen von 0,5-90 Gewichtsprozent, bevorzugt von 5 bis 50 Gewichtsprozent.Preparations that are diluted before use contain the active ingredient in concentrations of 0.5-90 percent by weight, preferably from 5 to 50 percent by weight.
Im allgemeinen hat es sich als vorteilhaft erwiesen, Mengen von etwa 1 bis etwa 100 mg Wirkstoff je kg Körpergewicht pro Tag zur Erzielung wirksamer Ergebnisse zu verabreichen. In general, it has proven to be advantageous Amounts from about 1 to about 100 mg of active ingredient per kg of body weight per day for effective results to administer.
Natürlich mit Toxascaris leonina infizierte Hunde wurden behandelt. Die Wirkstoffe wurden als reiner Wirkstoff in Gelatinekapseln oral appliziert.Dogs infected with Toxascaris leonina, of course treated. The active ingredients were as a pure active ingredient Orally applied in gelatin capsules.
Der Wirkungsgrad wird dadurch bestimmt, daß man die mit dem Kot ausgeschiedenen Würmer zählt. Anschließend wird die Anzahl der durch die Behandlung nicht abgetöteten und ausgeschiedenen Würmer nach Sektion der Hunde bestimmt.The efficiency is determined by using the excreted worms counts. Then will the number of those not killed by the treatment and excreted worms by section of the dogs certainly.
Experimentell mit Ancylostoma caninum bzw. Unicinaria stenocephala infizierte Hunde wurden nach Ablauf der Präparatezeit des Parasiten behandelt. Die Wirkstoffe wurden als reiner Wirkstoff in Gelatinekapseln oral appliziert.Experimental with Ancylostoma caninum or Unicinaria stenocephala infected dogs were found after the expiry of Preparation time of the parasite treated. The active ingredients were oral as a pure active ingredient in gelatin capsules applied.
Der Wirkungsgrad wird dadurch bestimmt, daß man die mit dem Kot ausgeschiedenen Würmer zählt. Anschließend wird die Anzahl der durch die Behandlung nicht abgetöteten und ausgeschiedenen Würmer nach Sektion der Hunde bestimmt.The efficiency is determined by using the excreted worms counts. Then will the number of those not killed by the treatment and excreted worms determined by section of the dogs.
Experimentell mit Nippostrongylus brasiliensis infizierte Ratten werden 6 Tage nach der Infektion an drei aufeinanderfolgenden Tagen oral mittels Schlundsonde behandelt. Die Tiere werden 12 Tage nach der Infektion getötet und die Zahl der Parasiten bestimmt. Es wird die Wirkstoffkonzentration angegeben, bei der 95% der Parasiten abgetötet wurden (effektive Dosis):Experimentally infected with Nippostrongylus brasiliensis Rats are given three to 6 days after infection consecutive days orally using a pharyngeal tube treated. The animals become 12 days after infection killed and the number of parasites determined. It will be the Drug concentration specified at which 95% of the Parasites were killed (effective dose):
Wirkstoffeffektive Dosis Beispiel Nr.mg/kgDrug effective dose Example Nr.mg/kg
4250 11004250 1100
Experimentell mit Haemonchus contortus infizierte Schafe wurden nach Ablauf der Präpatenzzeit des Parasiten behandelt. Die Wirkstoffe wurden als reiner Wirkstoff in Gelatinekapseln oral appliziert.Sheep experimentally infected with Haemonchus contortus were treated after the parasite's prepatent period. The active substances were used as pure active substances in Oral gelatin capsules.
Der Wirkungsgrad wird dadurch bestimmt, daß man die mit dem Kot ausgeschiedenen Würmer vor und nach der Behandlung quantitativ auszählt.The efficiency is determined by using the excreted worms before and after treatment counts quantitatively.
Ein völliges Sistieren der Eiausscheidung nach der Behandlung bedeutet, daß die Würmer abgetrieben wurden oder so geschädigt sind, daß sie keine Eier mehr produzieren (Dosis effectiva).Complete suspension of egg excretion after treatment means that the worms have been aborted or are so damaged that they no longer produce eggs (Effective dose).
Geprüfte Wirkstoffe und wirksame Dosierungen (Dosis effectiva) sind aus der nachfolgenden Tabelle ersichtlich:Tested active ingredients and effective doses (dose effectiva) are shown in the table below:
WirkstoffDosis effectiva in Beispiel Nr.mg/kgActive ingredient dose effectiva in Example Nr.mg/kg
450 325450 325
Experimentell mit Trichostrongylus colubriformis infizierte Schafe wurden nach Ablauf der Präpatenzzeit des Parasiten behandelt. Die Wirkstoffe wurden als reiner Wirkstoff in Gelatinekapseln oral appliziert.Experimental with Trichostrongylus colubriformis infected sheep became after the prepatent period of the parasite. The active substances were called pure active ingredient administered orally in gelatin capsules.
Der Wirkungsgrad wird dadurch bestimmt, daß man die mit dem Kot ausgeschiedenen Wurmeier vor und nach der Behandlung quantitativ auszählt.The efficiency is determined by using the Excreted worm eggs before and after treatment counts quantitatively.
Ein völliges Sistieren der Eiausscheidung nach der Behandlung bedeutet, daß die Würmer abgetrieben wurden oder so geschädigt sind, daß sie keine Eier mehr produzieren (Dosis effectiva).Complete suspension of egg excretion after treatment means that the worms have been aborted or are so damaged that they no longer produce eggs (Effective dose).
Geprüfte Wirkstoffe und wirksame Dosierungen (Dosis effectiva) sind aus der nachfolgenden Tabelle ersichtlich.Tested active ingredients and effective doses (dose effectiva) are shown in the table below.
WirkstoffDosis effectiva in Beispiel Nr.mg/kgActive ingredient dose effectiva in Example Nr.mg/kg
110 3 5110 3 5
Experimentell mit Metacercarien von Fasciola hepatica infizierte Ratten wurden nach der Infektion oral mittels Schlundsonde an drei aufeinanderfolgenden Tagen behandelt. Die Tiere wurden 2 Wochen nach der Infektion getötet und die Zahl der jugendlichen Leberegel im Leberparenchym bestimmt.Experimental with metacercariae from Fasciola hepatica infected rats were orally administered after infection Gavage treated for three consecutive days. The animals were sacrificed 2 weeks after infection and the number of juvenile liver fluke in the liver parenchyma certainly.
In der folgenden Tabelle wird angegeben, welche Dosis (effektive Dosis) erforderlich ist, um 95% Parasitenreduktion im Vergleich zu einer unbehandelten Kontrolle zu erreichen.The following table shows which dose (effective dose) is required to be 95% Parasite reduction compared to an untreated one To achieve control.
WirkstoffEffektive Dosis Beispiel Nr.ED₉₅ (mg/kg × 3)Effective dose Example No.ED₉₅ (mg / kg × 3)
1 25 3 10 4100 1 25 3 10 4100
0,1 Mol des N-Alkyl-N-hydroxi-carbamid-säureester der Formel II und 0,1 Mol des Alkylierungsmittels der Formel III werden zu einer Lösung von 6 g Kaliumhydroxid in 30 ml Ethanol gegeben und 5 h am Rückfluß gekocht. Der Alkohol wird abdestilliert und der rohe Ester mit Ether extrahiert. Nach Abdampfen des Ethers wird der Rückstand im Vakuum destilliert.0.1 mol of the N-alkyl-N-hydroxy-carbamide acid ester Formula II and 0.1 mole of the alkylating agent of the formula III become a solution of 6 g of potassium hydroxide in 30 ml of ethanol were added and the mixture was refluxed for 5 hours. The Alcohol is distilled off and the crude ester with ether extracted. After evaporation of the ether, the residue distilled in vacuo.
0,1 Mol des N,O-Dialkylhydroxylaminhydrochlorid der Formel (V) und 25 ml Wasser und 100 ml Ether werden vorgelegt und bei Raumtemperatur unter kräftigem Rühren mit 0,2 Mol Natriumhydrogencarbonat versetzt. Man rührt 40 min. bei Raumtemperatur nach, kühlt dann auf 0°C und tropft 0,1 Mol des Chlorameisensäureesters der Formel IV zu. Anschließend wird 24 h bei Raumtemperatur nachgerührt, die Etherphase abgetrennt, über Na₂SO₄ getrocknet und eingeengt. Der Rückstand wird analysiert (gaschromatographie) und gegebenenfalls im Vakuum destilliert. 0.1 mole of the N, O-dialkylhydroxylamine hydrochloride Formula (V) and 25 ml of water and 100 ml of ether submitted and at room temperature with vigorous stirring mixed with 0.2 mol of sodium hydrogen carbonate. You stir 40 min. at room temperature, then cools to 0 ° C and drips 0.1 mol of the chloroformic acid ester of the formula IV to. The mixture is then stirred at room temperature for 24 h, the ether phase separated, dried over Na₂SO₄ and constricted. The residue is analyzed (gas chromatography) and optionally in a vacuum distilled.
0,1 Mol des N-Alkoxycarbamidsäureesters der Formel VI und 0,1 Mol Natronlauge werden in 100 ml Methanol und 10 ml Wasser vorgelegt und bei Raumtemperatur mit 0,1 Mol des Alkylierungsreagenzes der Formel VII versetzt. Man rührt 48 h bei Raumtemperatur nach, dampft den Alkohol ab und extrahiert mit Ether. Die Etherextrakte werden getrocknet, der Ether abdestilliert und der Rückstand destilliert.0.1 mol of the N-alkoxycarbamic acid ester of the formula VI and 0.1 mol of sodium hydroxide solution in 100 ml of methanol and 10 ml of water are introduced and at room temperature 0.1 mole of the alkylating reagent of the formula VII was added. The mixture is stirred for 48 h at room temperature, the evaporated Alcohol and extracted with ether. The ether extracts are dried, the ether is distilled off and the residue distilled.
Analog einem der Verfahren 3a-c werden die Wirkstoffe
der folgenden Beispiele erhalten:
The active compounds of the following examples are obtained analogously to one of processes 3a-c:
Claims (6)
- a) Hydroxylaminderivate der Formel II,
in welcher
R¹ und R² die oben angegebene Bedeutung haben,
mit Verbindungen der Formel III,R³-X (III)in welcherR³die oben angegebene Bedeutung hat und Xfür Halogen oder p-Tolylsulfonyl steht,in Gegenwart von Basen umsetzt, oder - b) Kohlensäureester der Formel IV,
in welcherR¹die oben angegebene Bedeutung hat und
Yfür Halogen, Azido oder den Rest -O-R¹
steht,mit Hydroxylaminderivaten der Formel V oder
ihren Salzen mit Säuren,
in welcher
R² und R³ die oben angegebene Bedeutung
haben,
in Gegenwart von Basen umsetzt, oder - c) Hydroxylaminderivate der Formel VI,
in welcher
R¹ und R³ die oben angegebene Bedeutung
haben,
mit Verbindungen der Formel VII,R²-X (VII)in welcher X und R² die oben angegebene Bedeutung haben,
in Gegenwart von Basen umsetzt, oder - d) Carbamidsäurehalogenide der Formel VIII,
in welcherHalfür Halogen steht,
R² und R³die oben angegebene Bedeutung
haben,mit Verbindungen der Formel IX,R¹-OH (IX)in welcher
R¹ die oben angegebene Bedeutung hat,
in Gegenwart von Basen umsetzt.
- a) hydroxylamine derivatives of the formula II, in which R¹ and R² have the meaning given above,
with compounds of the formula III, R³-X (III) in which R³ has the meaning given above and X represents halogen or p-tolylsulfonyl, in the presence of bases, or - b) carbonic acid esters of the formula IV, in which R¹ has the meaning given above and Y represents halogen, azido or the radical -O-R¹, with hydroxylamine derivatives of the formula V or their salts with acids, in which R² and R³ have the meaning given above,
in the presence of bases, or - c) hydroxylamine derivatives of the formula VI, in which R¹ and R³ have the meaning given above,
with compounds of the formula VII, R²-X (VII) in which X and R² have the meaning given above,
in the presence of bases, or - d) carbamic acid halides of the formula VIII, in whichHal is halogen, R² and R³ have the meaning given above, with compounds of the formula IX, R¹-OH (IX) in which R¹ has the meaning given above,
implemented in the presence of bases.
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873716685 DE3716685A1 (en) | 1987-02-03 | 1987-05-19 | Use of N-organo-oxycarbamidates for controlling endoparasites, novel N-organo-oxycarbamidates, and processes for their preparation |
| US07/147,469 US4914124A (en) | 1987-02-03 | 1988-01-25 | N-organooxycarbamic acid esters for combating endoparasites |
| EP88101006A EP0277574A3 (en) | 1987-02-03 | 1988-01-25 | Use of n-organooxycarbamates against endoparasites, n-organooxycarbamates and process for their preparation |
| IL85275A IL85275A0 (en) | 1987-02-03 | 1988-02-01 | Endoparasiticidal compositions comprising n-organooxycarbamic acid esters,certain such novel compounds and their preparation |
| AU11133/88A AU1113388A (en) | 1987-02-03 | 1988-02-01 | N-organooxycarbamic acid esters for combating endoparasites |
| DK052488A DK52488A (en) | 1987-02-03 | 1988-02-02 | APPLICATION OF N-ORGANOXYCARBAMIC ACID ESTERS TO COMBAT ENDOPARASITIES AND N-ORGANOXYCARBAMI ACID EASTERS AND PROCEDURES FOR THEIR PREPARATION |
| HU88507A HUT47081A (en) | 1987-02-03 | 1988-02-03 | Process for producing pharmaceutical compositions against endogeneous parasites and a group of the active components, namely the new n-substituted oxy-carbonyl-esters |
| KR1019880000972A KR880009643A (en) | 1987-02-03 | 1988-02-03 | Use of N-organooxycarbamic acid ester for controlling parasites in the body, N-organooxycarbamic acid ester and preparation method thereof |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3703106 | 1987-02-03 | ||
| DE19873716685 DE3716685A1 (en) | 1987-02-03 | 1987-05-19 | Use of N-organo-oxycarbamidates for controlling endoparasites, novel N-organo-oxycarbamidates, and processes for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3716685A1 true DE3716685A1 (en) | 1988-08-11 |
Family
ID=25852123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19873716685 Withdrawn DE3716685A1 (en) | 1987-02-03 | 1987-05-19 | Use of N-organo-oxycarbamidates for controlling endoparasites, novel N-organo-oxycarbamidates, and processes for their preparation |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE3716685A1 (en) |
-
1987
- 1987-05-19 DE DE19873716685 patent/DE3716685A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0787141B1 (en) | Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process | |
| EP0626375B1 (en) | Octacyclodepsipeptides having endoparasiticidal activity | |
| EP0662326B1 (en) | Endoparasitical agents containing praziquantel and epsiprantel | |
| EP0626376A1 (en) | Octacyclodepsipeptides having endoparasiticidal activity | |
| EP0480258A2 (en) | Use of substituted 2-mercapto-nicotinic acid derivatives for combat against endoparasites, novel substituted 2-mercaptonicotinir acid derivatives and processes for their preparation | |
| EP0573883A1 (en) | Utilization of 3 substituted aryl-5-alkyl-isoxazole-4-carboxylic acid derivatives against endoparasites new 3-substituted aryl-5-alkyl-isoxazole-4-carboxylic acid derivatives and process for their preparation | |
| EP0403885A1 (en) | Utilization of 3-hydroxybenzothiophens for combatting endoparasites, new 3-hydroxythiophens and process for their preparation | |
| EP0664297B1 (en) | Use of cyclic Didepsipeptides having 12 ring atoms to control endoparasites, novel cyclic depsipeptides with 12 ring atoms and process for their synthesis | |
| DE4419814A1 (en) | Endoparasiticides | |
| EP0563686A1 (en) | Utilization of 3 substituted amino isoxazole derivatives against endoparasites, new 3 substituted amino isoxazols and process for their preparation | |
| EP0419918A2 (en) | Substituted 1,3,4-oxa(thia)-diazolinones, process for their preparation and their use in controlling endoparasites | |
| EP1189615B1 (en) | Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines | |
| EP0590415B1 (en) | 1,2,4-Oxadiazole derivatives for controlling endoparasites | |
| DE3804195A1 (en) | USE OF SWEAT-HOLDING N-ORGANO OXYCARBAMIDESE ACID ESTERS FOR THE CONTROL OF ENDOPARASITES, NEW N-ORGAN OXYC CARBAMIDE ACID ESTERS, AND METHOD FOR THE PRODUCTION THEREOF | |
| US5236939A (en) | Substituted 1,3,4-oxa(thia)diazolinones process for their preparation and their use of combating endoparasites | |
| EP0657172B1 (en) | Endoparasiticide drugs on a basis of open chain tetradepsipeptides | |
| DE19828047A1 (en) | New sulfonyl-substituted cyclooctadepsipeptide derivatives useful for prevention and treatment of helminth infection | |
| DE3925719A1 (en) | SUBSTITUTED THIENOPYRANONEES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THE CONTROL OF PARASITES | |
| US4914124A (en) | N-organooxycarbamic acid esters for combating endoparasites | |
| EP0492249B1 (en) | Use of substituted 1,2,4-oxadiazole derivatives for controlling endoparasites, new 1,2,4-oxadiazole derivatives and process for their preparation | |
| EP0421208A2 (en) | Substituted 1,3,4-thiadiazolones, process for their preparation and their use for controlling endoparasites | |
| DE3716685A1 (en) | Use of N-organo-oxycarbamidates for controlling endoparasites, novel N-organo-oxycarbamidates, and processes for their preparation | |
| EP0483631A1 (en) | 3-Oxy substituted isoxazolines, process for their preparation and their utilization against Endoparasites | |
| EP0657173A1 (en) | Endoparasiticide drugs on a basis of open chain hexadepsipeptides | |
| DE3731052A1 (en) | Use of N-organooxycarbamic acid esters for controlling endoparasites, novel N-organooxycarbamic acid esters and process for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8130 | Withdrawal |